S.No | LPL TEST NAME |
1 | ALLERGY, CANDIDA ALBICANS |
2 | ALLERGY, ASPERGILLUS FUMIGATUS |
3 | ALLERGY, MILK (Doodh) |
4 | ALLERGY, CLADOSPORIUM HERBARUM |
5 | ALLERGY, HOUSE DUST |
6 | ALLERGY, COCKROACH |
7 | ALLERGY, CAT EPITHELIUM & DANDER |
8 | ALLERGY, HORSE DANDER |
9 | ALLERGY, COW DANDER |
10 | ALLERGY, DOG DANDER |
11 | ALLERGY, EGG WHITE (Anda) |
12 | ALLERGY, SOYBEAN |
13 | ALLERGY, WHEAT (Gehu) |
14 | ALLERGY, SHRIMP (Prawn / Jhinga) |
15 | ALLERGY, PEANUT (Moongfali) |
16 | ALLERGY, BERMUDA GRASS (Cynodon dactylon / Doob) |
17 | ALLERGY, JOHNSON GRASS (Sorghum halepense / Jowar) |
18 | ALLERGY, ACACIA (Babool) |
19 | ALLERGY, MUG WORT (Artemisia vulgaris / Barna) |
20 | ALLERGY, WHITE PINE |
21 | ALLERGY, EUCALYPTUS (Nilgiri / Safeda) |
22 | ALLERGY, ALTERNARIA TENUIS |
23 | ALLERGY, RICE (Chawal) |
24 | ALLERGY, CHICKEN (Murgi) |
25 | ALLERGY, FISH (Machli) |
26 | ALLERGY, OLIVE |
27 | ALLERGY, WILLOW |
28 | ALLERGY, MELALEUCA |
29 | ALLERGY, OAT |
30 | ALLERGY, MAIZE (Bhutta) |
31 | ALLERGY, SESAME (Til) |
32 | ALLERGY, BUCKWHEAT (Kutu) |
33 | ALLERGY, PORK |
34 | ALLERGY, BEEF |
35 | ALLERGY, EGG YOLK (Anda) |
36 | ALLERGY, TURKEY |
37 | ALLERGY, TOMATO (Tamatar) |
38 | ALLERGY, YEAST |
39 | ALLERGY, GARLIC (Lasoon) |
40 | ALLERGY, ONION (Pyaaz) |
41 | ALLERGY, CELERY (Ajmoda) |
42 | ALLERGY, ORANGE (Santara) |
43 | ALLERGY, APPLE (Seb) |
44 | ALLERGY, BANANA (Kela) |
45 | ALLERGY, PEACH (Aaru) |
46 | ALLERGY, SPINACH (Palak) |
47 | ALLERGY, CABBAGE (Bandgobi) |
48 | ALLERGY, PAPRIKA |
49 | ALLERGY, STRAWBERRY |
50 | ALLERGY, PEAR (Nashpati) |
51 | ALLERGY, LEMON (Neembu) |
52 | ALLERGY, PINEAPPLE (Ananas) |
53 | ALLERGY, CARROT (Gajar) |
54 | ALLERGY, POTATO (Aloo) |
55 | ALLERGY, CUCUMBER (Kheera) |
56 | ALLERGY, PECAN |
57 | ALLERGY, CASHEWNUT (Kaju) |
58 | ALLERGY, PISTACHIO (Pista) |
59 | ALLERGY, WALNUT (Akhrot) |
60 | ALLERGY, LENTIL (Dal) |
61 | ALLERGY, PEA (Matar) |
62 | ALLERGY, WHITE BEAN |
63 | ALLERGY, CAROB |
64 | ALLERGY, CHICKPEA (Kabuli chana) |
65 | ALLERGY, COCOA |
66 | ALLERGY, COFFEE |
67 | ALLERGY, CHEDDAR (Cheese) |
68 | ALLERGY, RYE |
69 | ALLERGY, ALMOND (Badam) |
70 | ALLERGY, COCONUT (Nariyal) |
71 | ALLERGY, CASEIN |
72 | ALLERGY, LOBSTER |
73 | ALLERGY, MUTTON (Meat) |
74 | ALLERGY, MANGO (Aam) |
75 | ALLERGY, RYEGRASS |
76 | ALLERGY, TIMOTHY GRASS |
77 | ALLERGY, MEADOW GRASS (Lawn grass) |
78 | ALLERGY, BAHIA GRASS |
79 | ALLERGY, RAGWEED |
80 | ALLERGY, GOOSEFOOT (Bathua) |
81 | ALLERGY, COMMON PIGWEED (Kantewali Chauli) |
82 | ALLERGY, ELM (Papdi Chibil) |
83 | ALLERGY, MESQUITE (Pahari Keekar) |
84 | ALLERGY, BRINJAL (Baingan) |
85 | ALLERGY, ALDER (Bhidur) |
86 | ALLERGY, OAK |
87 | ALLERGY, COTTONWOOD |
88 | ALLERGY, MULBERRY (Shahtoot) |
89 | ALLERGY, COCKLEBUR (Bichha / Kutta) |
90 | ALLERGY, RAPESEED (Sarson) |
91 | ALLERGY, MUSHROOM (Kukurmutta) |
92 | ALLERGY PHADIATOP, ADULT |
93 | ALLERGY PHADIATOP, PEDIATRIC |
94 | ALLERGY, MUSSEL |
95 | ALLERGY, SALMON |
96 | ALLERGY, TUNA |
97 | GLUCOSE, FASTING (F) |
98 | GLUCOSE, POST PRANDIAL (PP), 2 HOURS |
99 | GLUCOSE, RANDOM (R) |
100 | UREA, SERUM |
101 | BUN; BLOOD UREA NITROGEN |
102 | CREATININE, SERUM |
103 | URIC ACID, SERUM |
104 | CHOLESTEROL, TOTAL |
105 | TRIGLYCERIDES, SERUM |
106 | CK; CREATINE KINASE |
107 | HBDH; ALPHA – HYDROXYBUTYRATE DEHYDROGENASE |
108 | LDH; LACTATE DEHYDROGENASE |
109 | SGOT; ASPARTATE AMINOTRANSFERASE (AST) |
110 | SGPT; ALANINE AMINOTRANSFERASE (ALT) |
111 | GGTP (GAMMA GLUTAMYL TRANSPEPTIDASE) |
112 | BILIRUBIN, TOTAL |
113 | BILIRUBIN, DIRECT |
114 | ALBUMIN, SERUM |
115 | ALKALINE PHOSPHATASE; ALP |
116 | CALCIUM, SERUM |
117 | PHOSPHORUS, SERUM |
118 | SODIUM, SERUM |
119 | POTASSIUM, SERUM |
120 | CHLORIDE, SERUM |
121 | AMYLASE, SERUM |
122 | CPK-MB |
123 | ALDOLASE |
124 | CALCIUM, IONIZED |
125 | LIPASE |
126 | AMMONIA, BLOOD |
127 | ANGIOTENSIN CONVERTING ENZYME; ACE |
128 | CHOLINESTERASE, SERUM |
129 | MAGNESIUM, SERUM |
130 | LITHIUM |
131 | FRUCTOSAMINE |
132 | RHEUMATOID FACTOR (RA), SERUM |
133 | ANTI STREPTOLYSIN – O (ASO) TITRE |
134 | C-REACTIVE PROTEIN; CRP |
135 | ANTI DNase B; ANTIDEOXYRIBONUCLEASE B |
136 | IMMUNOGLOBULIN IgG, SERUM |
137 | IMMUNOGLOBULIN IgA, SERUM |
138 | IMMUNOGLOBULIN IgM, SERUM |
139 | HbA1c; GLYCOSYLATED HEMOGLOBIN |
140 | CERULOPLASMIN |
141 | FIBRINOGEN, CLOTTING ACTIVITY |
142 | PROTEIN, TOTAL, CSF |
143 | IMMUNOGLOBULIN IgG, CSF |
144 | ALBUMIN, CSF |
145 | LACTATE, CSF |
146 | LACTATE, PLASMA |
147 | LIPOPROTEIN (a); Lp(a) |
148 | LACTATE, PLASMA, POST EXERCISE |
149 | HDL CHOLESTEROL, DIRECT |
150 | LDL CHOLESTEROL, DIRECT |
151 | LIPID PROFILE, BASIC |
152 | C-REACTIVE PROTEIN, CARDIO; hsCRP |
153 | SERUM ASCITES ALBUMIN GRADIENT (SAAG) |
154 | MICROALBUMIN/ALBUMIN CREATININE RATIO, URINE |
155 | PAPP-A (PREGNANCY ASSOCIATED PLASMA PROTEIN-A) |
156 | ANTI SOLUBLE LIVER ANTIGEN; SLA |
157 | TORCH PANEL AVIDITY, IGG |
158 | CYTOMEGALOVIRUS (CMV) AVIDITY, IgG |
159 | TOXOPLASMA AVIDITY, IgG |
160 | RUBELLA (GERMAN MEASLES) AVIDITY, IGG |
161 | BICARBONATE, SERUM |
162 | GFR (GLOMERULAR FILTRATION RATE),ESTIMATED |
163 | CYSTATIN C |
164 | BETA 2 GLYCOPROTEIN 1, IgG |
165 | BETA 2 GLYCOPROTEIN 1, IgM |
166 | BETA 2 GLYCOPROTEIN 1, IgA |
167 | SODIUM : OSMOLALITY RATIO, SERUM |
168 | OSMOLAL GAP, SERUM |
169 | FRACTIONAL EXCRETION OF SODIUM |
170 | GLUCOSE CHALLENGE TEST (GCT), PREGNANCY, 75G GLUCOSE |
171 | GLUCOSE TOLERANCE TEST (GTT), PREGNANCY, 100g GLUCOSE |
172 | COPPER, SERUM |
173 | STONE ANALYSIS WITH PICTURE |
174 | DIGOXIN |
175 | VALPROIC ACID; VALPROATE |
176 | PHENYTOIN |
177 | PHENOBARBITONE |
178 | CARBAMAZEPINE |
179 | PROTEIN ELECTROPHORESIS, SERUM |
180 | HEMOGLOBIN HPLC/ELECTROPHORESIS |
181 | LIPID PROFILE, COMPLETE |
182 | AFP (ALPHA FETOPROTEIN), TUMOR MARKER |
183 | HCG, BETA, TOTAL, QUANTITATIVE, TUMOR MARKER |
184 | CEA; CARCINO EMBRYONIC ANTIGEN |
185 | CA 125; OVARIAN CANCER MARKER |
186 | CA 19.9; PANCREATIC CANCER MARKER |
187 | CA 72.4; GASTRIC CANCER MARKER |
188 | CA 15.3; BREAST CANCER MARKER |
189 | PSA (PROSTATE – SPECIFIC ANTIGEN), TOTAL |
190 | PSA (PROSTATE – SPECIFIC ANTIGEN), FREE |
191 | INHIBIN A, PREGNANCY |
192 | INHIBIN A, REPRODUCTIVE MARKER |
193 | GLUCOSE ESTIMATION, 2.5 HOURS |
194 | GLUCOSE ESTIMATION EXTENDED, 5 HOURS |
195 | GLUCOSE CHALLENGE TEST (GCT); GLUCOSE 1 HOUR OBSTETRICAL |
196 | GLUCOSE TOLERANCE TEST (GTT), PREGNANCY, 75g GLUCOSE |
197 | GLUCOSE TOLERANCE TEST, ORAL (OGTT) |
198 | ALKAPTONURIA, URINE, QUALITATIVE |
199 | METHYLMALONIC ACID, QUALITATIVE, URINE |
200 | AMINO ACIDS, QUALITATIVE, ONE DIMENSIONAL, URINE |
201 | AMINO ACIDS, QUALITATIVE, PLASMA |
202 | AMINO ACIDS, QUALITATIVE, CSF |
203 | AMINO ACIDS, QUALITATIVE, TWO DIMENSIONAL, URINE |
204 | MUCOPOLYSACCHARIDOSIS (MPS) SCREEN, URINE |
205 | GALACTOSEMIA SCREENING, BLOOD |
206 | DNPH, URINE |
207 | FERRIC CHLORIDE TEST, URINE |
208 | NITROSONAPHTHOL, URINE |
209 | CITRATE, 24-HOUR URINE |
210 | NEWBORN SCREENING PANEL1 |
211 | NEWBORN SCREENING PANEL2 |
212 | NEWBORN SCREENING PANEL 3 |
213 | NEWBORN SCREENING PANEL -4 |
214 | HEMOGLOBIN; Hb |
215 | PACKED CELL VOLUME (PCV); HEMATOCRIT |
216 | TLC (TOTAL LEUCOCYTE COUNT) |
217 | RED BLOOD CELLS; RBC COUNT |
218 | MEAN CORPUSCULAR VOLUME; MCV |
219 | MEAN CORPUSCULAR HEMOGLOBIN; MCH |
220 | MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION; MCHC |
221 | ESR; ERYTHROCYTE SEDIMENTATION RATE |
222 | RETICULOCYTE COUNT |
223 | OSMOTIC FRAGILITY TEST; RBC FRAGILITY TEST |
224 | PARTIAL THROMBOPLASTIN TIME, ACTIVATED; PTT; APTT |
225 | BLEEDING TIME; BT |
226 | CLOTTING TIME; CT |
227 | G-6-PD, QUANTITATIVE |
228 | RED CELL DISTRIBUTION WIDTH; RDW |
229 | IRON STUDIES |
230 | ABSOLUTE EOSINOPHIL COUNT; AEC |
231 | DLC (DIFFERENTIAL LEUCOCYTE COUNT), AUTOMATED |
232 | MICROFILARIA DETECTION |
233 | FIBRINOGEN DEGRADATION PRODUCTS (FDP), BLOOD |
234 | COOMBS TEST, INDIRECT |
235 | COOMBS TEST, DIRECT |
236 | BLOOD PICTURE; PERIPHERAL BLOOD SMEAR EXAMINATION |
237 | MALARIA PARASITE / BLOOD PARASITE IDENTIFICATION |
238 | MEAN PLATELET VOLUME; MPV |
239 | LE CELL PHENOMENON |
240 | CLOT RETRACTION TEST |
241 | THROMBIN TIME; TT |
242 | FACTOR XIII (CLOT SOLUBILITY), FUNCTIONAL, QUALITATIVE |
243 | SICKLING, SCREENING TEST |
244 | ANTI A TITRE, IgM |
245 | ANTI B TITRE, IgM |
246 | ABSOLUTE NEUTROPHIL COUNT |
247 | ABSOLUTE LYMPHOCYTE COUNT |
248 | FERRITIN |
249 | TYPHI DOT/ SALMONELLA TYPHI IgM |
250 | ANTI A TITRE, IGG |
251 | ANTI B TITRE, IGG |
252 | C3 COMPLEMENT |
253 | C4 COMPLEMENT |
254 | CRYOGLOBULINS QUALITATIVE TEST |
255 | HAM TEST; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH), SCREENING TEST |
256 | LUPUS ANTICOAGULANT BY APTT; PTT – LA |
257 | TRANSFERRIN |
258 | PROTHROMBIN TIME STUDIES |
259 | D – DIMER, QUANTITATIVE |
260 | HEINZ BODIES, PERIPHERAL BLOOD |
261 | BLOOD GROUP ABO & RH FACTOR |
262 | PLATELET DISTRIBUTION WIDTH; PDW |
263 | BONE MARROW, IRON STAIN |
264 | COAGULATION SCREEN |
265 | MALARIA PARASITE CONFIRMATION |
266 | IMMATURE PLATELET FRACTION (IPF) |
267 | PLATELET COUNT, FLUORESCENT (PLT-F) |
268 | HISTOPATHOLOGY, BIOPSY, SMALL SPECIMEN |
269 | BUCCAL SMEAR FOR BARR BODIES (SEX CHROMATIN) |
270 | CYTOLOGY, FINE NEEDLE ASPIRATION; FNAC |
271 | CYTOLOGY (PAP SMEAR), GENITAL, FEMALE, CONVENTIONAL |
272 | HISTOPATHOLOGY, BIOPSY – SECOND OPINION |
273 | CYTOLOGY CONSULTATION, SECOND OPINION |
274 | ESTROGEN RECEPTOR; ER |
275 | IMMUNOHISTOCHEMISTRY, PROGESTERONE RECEPTOR (PR) |
276 | CYTOLOGY EXAMINATION, BODY FLUIDS |
277 | HlSTOPATHOLOGY, BIOPSY, LARGE SPECIMEN |
278 | HISTOPATHOLOGY, DIRECT IMMUNO-FLUORESCENCE (DIF),SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C3 |
279 | HISTOPATHOLOGY, DIRECT IMMUNOFLUORESCENCE (DIF), SKIN / CONJUNCTIVAL BIOPSY, IgA |
280 | HISTOPATHOLOGY, DIRECT IMMUNO-FLUORESCENCE (DIF),SKIN / CONJUNCTIVAL BIOPSY, IgG |
281 | HISTOPATHOLOGY, DIRECT IMMUNO-FLUORESCENCE (DIF),SKIN / CONJUNCTIVAL BIOPSY, IgM |
282 | HISTOPATHOLOGY, DIRECT IMMUNO-FLUORESCENCE (DIF),SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C1q |
283 | HISTOPATHOLOGY, SPECIAL STAIN, ACID FAST (Z.N STAIN) |
284 | HISTOPATHOLOGY, SPECIAL STAIN, AMYLOID (CONGO RED) |
285 | HISTOPATHOLOGY, SPECIAL STAIN, IRON (PERL’S STAIN) |
286 | HISTOPATHOLOGY, SPECIAL STAIN, PERIODIC ACID SCHIFF (PAS) |
287 | SUDAN IV STAIN |
288 | HISTOPATHOLOGY, SPECIAL STAIN, RETICULIN |
289 | CYTOLOGY, CELL BLOCK EXAMINATION |
290 | HISTOPATHOLOGY, SPECIAL STAIN, FONTANA MASSON |
291 | HISTOPATHOLOGY, SPECIAL STAIN, GOMORI’S METHENAMINE SILVER |
292 | HISTOPATHOLOGY, SPECIAL STAIN, MUCICARMINE |
293 | HISTOPATHOLOGY, SPECIAL STAIN, MASSON TRICHROME |
294 | HISTOPATHOLOGY, SPECIAL STAIN, PHOSPHOTUNGSTIC ACID HEMATOXYLIN (PTAH) |
295 | HISTOPATHOLOGY, SPECIAL STAIN, VAN GIESONS |
296 | HISTOPATHOLOGY, SPECIAL STAIN, ALCIAN BLUE |
297 | HISTOPATHOLOGY, BIOPSY, MEDIUM SPECIMEN |
298 | HISTOPATHOLOGY, SPECIAL STAIN, COPPER (RHODANINE) |
299 | HISTO / CYTOPATHOLOGY / IMMUNOHISTOCHEMISTRY (IHC), PHOTOMICROGRAPH |
300 | HISTOPATHOLOGY, POLARISING MICROSCOPY |
301 | HISTOPATHOLOGY, BIOPSY, BONE |
302 | HISTO/CYTOPATHOLOGY, SLIDE(S) / BLOCK(S), ISSUE |
303 | CYTOLOGY (PAP SMEAR), GENITAL, FEMALE, LIQUID BASED |
304 | OPIATES SCREEN, RANDOM URINE |
305 | BENZODIAZEPINE SCREEN, QUALITATIVE, URINE |
306 | CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA, SCREEN, URINE |
307 | COCAINE & METABOLITE SCREEN, URINE |
308 | AMPHETAMINE SCREEN, URINE |
309 | BARBITURATE SCREEN, QUALITATIVE, URINE |
310 | PHENCYCLIDINE (PCP), SCREEN, URINE |
311 | ALCOHOL (ETHANOL) SCREEN, SERUM |
312 | METHAMPHETAMINE SCREEN, URINE |
313 | PROPOXYPHENE SCREEN, URINE |
314 | METHAQUALONE SCREEN, URINE |
315 | METHADONE SCREEN, URINE |
316 | NICOTINE SCREEN,URINE |
317 | CULTURE, URINE |
318 | CULTURE, STOOL |
319 | CULTURE, AEROBIC, THROAT SWAB |
320 | CULTURE, AEROBIC, BLOOD, RAPID |
321 | CULTURE, AEROBIC, SPUTUM |
322 | CULTURE, AEROBIC, PUS |
323 | CULTURE, AEROBIC, SEMEN |
324 | CULTURE, AEROBIC, EYE SWAB |
325 | CULTURE, AEROBIC, EAR SWAB |
326 | CULTURE, AEROBIC, VAGINAL SWAB |
327 | CULTURE, AEROBIC, NASAL SWAB |
328 | CULTURE, GONOCOCCUS |
329 | CULTURE, AEROBIC, MISCELLANEOUS |
330 | CULTURE, ANAEROBIC, BLOOD, RAPID |
331 | CULTURE, FUNGUS, BLOOD / BODY FLUIDS RAPID |
332 | CULTURE, WATER; PRESUMPTIVE COLIFORM COUNT |
333 | CULTURE, AFB (MYCOBACTERIUM), RAPID |
334 | CULTURE, ANAEROBIC |
335 | CULTURED AEROBIC BACTERIA IDENTIFICATION |
336 | CULTURE, CLOSTRIDIUM DIFFICILE |
337 | CULTURE, ACTINOMYCES |
338 | CULTURE, CHOLERA |
339 | CULTURE, DIPHTHERIA |
340 | CULTURED ANAEROBIC BACTERIA IDENTIFICATION |
341 | CULTURED FUNGUS IDENTIFICATION |
342 | CULTURE, HAEMOPHILUS |
343 | CULTURE, NOCARDIA |
344 | CULTURE, FUNGUS |
345 | CULTURE, AEROBIC, BODY FLUIDS, RAPID |
346 | CULTURE, ANAEROBIC, BODY FLUID, RAPID |
347 | YEAST (CANDIDA SPECIES) IDENTIFICATION |
348 | YEAST (CANDIDA SPECIES) SUSCEPTIBILITY TESTING |
349 | CULTURED AEROBIC BACTERIA SENSITIVITY |
350 | CULTURE, AEROBIC, CSF |
351 | RAPID TB ANTIGEN MPT64 |
352 | MALDITOF – MS MYCOBACTERIUM SPECIATION |
353 | NOCARDIA, STAIN |
354 | MODIFIED ACID FAST STAIN FOR LEPROSY |
355 | MALDITOF-MS YEAST IDENTIFICATION |
356 | MALDITOF-MS BACTERIA IDENTIFICATION |
357 | MALDITOF-MS MOLD IDENTIFICATION |
358 | Z-N STAIN; ZIEHL NEELSEN STAIN |
359 | CULTURE ESBL (EXTENDED SPECTRUM BETA-LACTAMASE), SCREENING |
360 | CULTURE MRSA (METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS), SCREENING |
361 | CULTURE KPC (CARBAPENEMASE), SCREENING |
362 | ROTAVIRUS ANTIGEN, STOOL |
363 | GROUP A STREPTOCOCCAL ANTIGEN |
364 | VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) , SCREENING |
365 | LEISHMANIA (KALA AZAR) RK-39 ANTIBODY, SERUM |
366 | SALMONELLA TYPHI AND SALMONELLA PARATYPHI A ANTIGEN DETECTION |
367 | HELICOBACTER PYLORI ANTIGEN, RAPID STOOL TEST |
368 | OPPORTUNISTIC ENTERIC PARASITE SCREEN, STOOL |
369 | CHLAMYDIA ANTIGEN,RAPID |
370 | CULTURE GROUP B STREPTOCOCCUS(GBS) , DOES NOT INCLUDE SENSITIVITY |
371 | CULTURE,AEROBIC,BRONCHOALVEOLAR LAVAGE(BAL) |
372 | CULTURE,AEROBIC,ENDOTRACHEAL (ET) SECRETIONS |
373 | HPV (HUMAN PAPILLOMA VIRUS) DETECTION & GENOTYPING, QUALITATIVE, PCR |
374 | BLOOD GAS ANALYSIS, ARTERIAL |
375 | BLOOD GAS ANALYSIS, VENOUS |
376 | SEMEN ANALYSIS; SEMINOGRAM |
377 | MANTOUX TEST; TUBERCULIN SKIN TEST |
378 | FLUID EXAMINATION, ROUTINE, CSF/ NASAL FLUID |
379 | FLUID EXAMINATION, ROUTINE, BODY FLUIDS |
380 | SPUTUM EXAMINATION, ROUTINE |
381 | THROAT SWAB, ROUTINE |
382 | SMEAR EXAMINATION, ROUTINE |
383 | FUNGUS EXAMINATION, ROUTINE, KOH CALCOFLUOR WHITE PREPARATION |
384 | SEMEN FRUCTOSE, QUALITATIVE |
385 | GRAM STAIN |
386 | SPUTUM EXAMINATION, AFB |
387 | SMEAR EXAMINATION, GONOCOCCUS |
388 | AFB STAIN, MISCELLANEOUS |
389 | INDIA INK PREPARATION, CSF |
390 | LDH (LACTATE DEHYDROGENASE), FLUID |
391 | AMYLASE, FLUID |
392 | CHOLESTEROL, FLUID |
393 | TRIGLYCERIDES, FLUID |
394 | CULTURE, AEROBIC, MISCELLANEOUS WITH GRAM STAIN |
395 | OSMOLALITY, SERUM |
396 | SPUTUM FOR EOSINOPHILS |
397 | SPUTUM EXAMINATION, OVA & PARASITES |
398 | INDIA INK PREPARATION, FLUID |
399 | RHEUMATOID FACTOR (RA), SYNOVIAL FLUID |
400 | CHYLE EXAMINATION |
401 | SODIUM, FLUID |
402 | CREATININE, FLUID |
403 | TLC (TOTAL LEUCOCYTE COUNT), FLUID |
404 | DLC ( DIFFERENTIAL LEUCOCYTE COUNT), FLUID |
405 | GLUCOSE, FLUID |
406 | ALBUMIN, FLUID |
407 | UREA, FLUID |
408 | CHLORIDE, FLUID |
409 | PROTEIN, TOTAL, BODY FLUIDS |
410 | PACKED CELL VOLUME (PCV), BODY FLUIDS |
411 | ALBERT STAIN |
412 | ECHINOCOCCUS DETECTION FOR SCOLICES IN HYDATID CYST FLUID |
413 | POLARIZING MICROSCOPY, BODY FLUIDS |
414 | POTASSIUM, FLUID |
415 | BILIRUBIN, FLUID |
416 | AFFYMETRIX MICROARRAY GENECHIP SCANNING |
417 | TESTOSTERONE, TOTAL |
418 | PROGESTERONE, SERUM |
419 | CORTISOL, SERUM (MORNING SAMPLE) |
420 | CORTISOL, SERUM (EVENING SAMPLE) |
421 | ESTRADIOL (E2), SERUM |
422 | GASTRIN |
423 | HCG, BETA, TOTAL, QUANTITATIVE, MATERNAL |
424 | AFP (ALPHA FETOPROTEIN), MATERNAL |
425 | GROWTH HORMONE; GH |
426 | INSULIN, FASTING |
427 | ACTH |
428 | INSULIN, RANDOM |
429 | INSULIN, PP |
430 | CORTISOL, MIDNIGHT, SERUM |
431 | DHEA SULPHATE; DEHYDROEPIANDROSTERONE SULPHATE |
432 | FOLATE (FOLIC ACID), SERUM |
433 | VITAMIN B12; CYANOCOBALAMIN |
434 | T3, TOTAL |
435 | T4, TOTAL |
436 | TSH (THYROID STIMULATING HORMONE) |
437 | 17 – HYDROXYPROGESTERONE (17-OHP) |
438 | C-PEPTIDE, FASTING, SERUM |
439 | BETA – 2 – MICROGLOBULIN, SERUM |
440 | FSH; FOLLICLE STIMULATING HORMONE |
441 | LH; LUTEINISING HORMONE |
442 | PROLACTIN, SERUM |
443 | T3, FREE; FT3 |
444 | T4, FREE; FT4 |
445 | TSH (THYROID STIMULATING HORMONE), ULTRASENSITIVE |
446 | ESTRIOL UNCONJUGATED / FREE (µE3) |
447 | HOMOCYSTEINE, QUANTITATIVE, SERUM |
448 | ADENOSINE DEAMINASE ; ADA |
449 | C-PEPTIDE, POST PRANDIAL, SERUM |
450 | G-6-PD, NEWBORN SCREEN |
451 | TSH, NEWBORN SCREEN |
452 | PHENYLALANINE, NEWBORN SCREEN |
453 | CYSTIC FIBROSIS, NEWBORN, SCREEN |
454 | 17 – HYDROXYPROGESTERONE, NEWBORN SCREEN; CAH SCREEN |
455 | GALACTOSEMIA, NEWBORN SCREEN |
456 | BIOTINIDASE, NEWBORN SCREEN |
457 | CK-MB MASS |
458 | TSH ULTRASENSITIVE, CORD BLOOD |
459 | TPHA; TREPONEMA PALLIDUM HEMAGGLUTINATION |
460 | WEIL FELIX TEST |
461 | BRUCELLA AGGLUTINATION TEST |
462 | MONO TEST (INFECTIOUS MONONUCLEOSIS) |
463 | PREGNANCY TEST, URINE |
464 | RPR, SERUM |
465 | HIV 1 & 2 ANTIBODIES, SCREENING TEST |
466 | VDRL, CSF |
467 | ANTI SPERM ANTIBODY, SERUM |
468 | AMOEBIC SEROLOGY, IgG, SERUM |
469 | TOXOPLASMA ANTIBODY, IgM |
470 | RUBELLA (GERMAN MEASLES) ANTIBODY, IgM |
471 | HISTONE ANTIBODIES |
472 | HERPES SIMPLEX VIRUS (HSV) 1+2, IgG, SERUM |
473 | CYTOMEGALOVIRUS (CMV) ANTIBODY, IgM |
474 | ALDEHYDE CHOPRA TEST FOR KALA AZAR |
475 | WIDAL SLIDE AGGLUTINATION TEST |
476 | ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), EIA |
477 | IMMUNOGLOBULIN IgE, SERUM |
478 | ANTI – ds DNA ANTIBODY, EIA |
479 | CYSTICERCOSIS (TAENIA SOLIUM) ANTIBODY, IgG |
480 | ECHINOCOCCUS (HYDATID SEROLOGY) IgG, SERUM |
481 | Sm (SMITH) ANTIBODY, IgG |
482 | TOXOPLASMA ANTIBODY, IgG |
483 | RUBELLA (GERMAN MEASLES) ANTIBODY, IgG |
484 | CYTOMEGALOVIRUS (CMV) ANTIBODY, IgG |
485 | CARDIOLIPIN ANTIBODY, IgA |
486 | CARDIOLIPIN ANTIBODY, IgM |
487 | CARDIOLIPIN ANTIBODY, IgG |
488 | HEPATITIS B SURFACE ANTIGEN; HBsAg; AUSTRALIA ANTIGEN |
489 | HEPATITIS B SURFACE ANTIBODY; ANTI HBs |
490 | HEPATITIS B CORE ANTIBODY (Anti-HBC), IGM |
491 | HEPATITIS Be ANTIGEN; HBeAg |
492 | HEPATITIS BE ANTIBODY; Anti-Hbe |
493 | HEPATITIS A ANTIBODY (Anti-HAV), IGM |
494 | HEPATITIS C ANTIBODY (Anti-HCV) |
495 | Scl-70 (SCLERODERMA) ANTIBODY |
496 | SS-A/Ro ANTIBODY |
497 | SS-B/La ANTIBODY |
498 | HERPES SIMPLEX VIRUS (HSV) 1+2, IgM, SERUM |
499 | VARICELLA ZOSTER VIRUS (VZV) ANTIBODY, IgM |
500 | VARICELLA ZOSTER VIRUS (VZV) ANTIBODY, IgG |
501 | CENTROMERE ANTIBODY |
502 | Jo-1 ANTIBODY |
503 | PARIETAL CELL ANTIBODY, IFA |
504 | HEPATITIS A ANTIBODY (Anti-HAV), IGG |
505 | ANTI THYROID PEROXIDASE ANTIBODY; ANTI TPO |
506 | ANTI THYROGLOBULIN ANTIBODY; ANTI Tg |
507 | GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY, IFA |
508 | HEPATITIS B CORE ANTIBODY (Anti-HBC), TOTAL |
509 | HEPATITIS B SURFACE ANTIGEN (HBsAg) CONFIRMATION |
510 | STREPTOCOCCUS GROUP B ANTIGEN DETECTION |
511 | MALARIA VIVAX AND FALCIPARUM ANTIGEN |
512 | RHEUMATOID FACTOR, IgA |
513 | LEPTOSPIRA ANTIBODY, IgG |
514 | FILARIA ANTIGEN |
515 | PHOSPHOLIPID ANTIBODY, IgG |
516 | PHOSPHOLIPID ANTIBODY, IgM |
517 | TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY, IgA |
518 | LEPTOSPIRA ANTIBODY, IgM |
519 | WIDAL TUBE AGGLUTINATION TEST |
520 | CHIKUNGUNYA VIRUS ANTIBODY, IgM |
521 | HERPES SIMPLEX VIRUS (HSV) 1 IgG, SERUM |
522 | HERPES SIMPLEX VIRUS (HSV) 2 IgG, SERUM |
523 | HERPES SIMPLEX VIRUS (HSV) 1 IgM, SERUM |
524 | HERPES SIMPLEX VIRUS (HSV) 2 IgM, SERUM |
525 | HEPATITIS B SURFACE ANTIGEN (HBsAg), QUANTITATIVE |
526 | DENGUE FEVER IgM ANTIBODY, EIA |
527 | DENGUE FEVER IgG ANTIBODY, EIA |
528 | ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY), IgG |
529 | ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY), IgA |
530 | BRUCELLA ANTIBODY, IgG |
531 | BRUCELLA ANTIBODY, IgM |
532 | DENGUE FEVER NS1 ANTIGEN, EIA |
533 | CHLAMYDIA TRACHOMATIS IgG |
534 | TISSUE TRANSGLUTAMINASE (TTG) ANTIBODY, IGG |
535 | PREGNANCY ASSOCIATED PLASMA PROTEIN A (PAPP-A), SERUM |
536 | FREE BETA HCG , SERUM |
537 | STOOL EXAMINATION, ROUTINE; STOOL, R/E |
538 | STOOL EXAMINATION, OCCULT BLOOD |
539 | STOOL EXAMINATION, pH & REDUCING SUBSTANCES |
540 | CRYPTOSPORIDIUM / ISOSPORA IDENTIFICATION, STOOL |
541 | STOOL EXAMINATION, HANGING DROP PREPARATION |
542 | URINE EXAMINATION, ROUTINE; URINE, R/E |
543 | PROTEIN, TOTAL, 24-HOUR URINE |
544 | CREATININE, 24-HOUR URINE |
545 | URIC ACID, 24 HOUR URINE |
546 | CALCIUM, 24 HOUR URINE |
547 | PHOSPHORUS, 24-HOUR URINE |
548 | SODIUM, RANDOM URINE |
549 | POTASSIUM, RANDOM URINE |
550 | CHLORIDE, RANDOM URINE |
551 | AMYLASE (DIASTASE), URINE |
552 | SPECIFIC GRAVITY, URINE |
553 | MAGNESIUM, 24-HOUR URINE |
554 | PROTEIN, TOTAL, RANDOM URINE |
555 | CORTISOL, FREE, 24-HOUR URINE |
556 | HCG, BETA, TOTAL, QUANTITATIVE, 24 HOUR URINE |
557 | SODIUM, 24-HOUR URINE |
558 | UREA NITROGEN, 24 HOUR URINE |
559 | MICROALBUMIN/ALBUMIN, 1ST MORNING / RANDOM URINE |
560 | UREA, 24 HOUR URINE |
561 | MICROALBUMIN/ALBUMIN, 24-HOUR URINE |
562 | OSMOLALITY, URINE |
563 | CHLORIDE, 24-HOUR URINE |
564 | CREATININE, RANDOM URINE |
565 | HEMOGLOBIN, FREE, URINE |
566 | BETA – 2 – MICROGLOBULIN, 24 HOUR URINE |
567 | POTASSIUM, 24-HOUR URINE |
568 | MAGNESIUM, RANDOM URINE |
569 | UROBILINOGEN, QUALITATIVE, 24 HOUR URINE |
570 | URINE FOR EOSINOPHILS |
571 | URINE, DYSMORPHIC RBC |
572 | CALCIUM, RANDOM URINE |
573 | PHOSPHORUS, RANDOM URINE |
574 | HCG, BETA, TOTAL, QUANTITATIVE, RANDOM URINE |
575 | UREA, RANDOM URINE |
576 | URIC ACID, RANDOM URINE |
577 | URINE, REDUCING SUBSTANCES |
578 | URINE, GLUCOSE |
579 | PROTEIN – CREATININE RATIO, URINE |
580 | C-PEPTIDE, 24-HOUR URINE |
581 | CALCIUM / CREATININE RATIO, RANDOM URINE |
582 | CALCIUM EXCRETION 2 HOUR FASTING URINE |
583 | OSMOLALITY, URINE : SERUM RATIO |
584 | UREA NITROGEN, RANDOM URINE |
585 | BENCE JONES PROTEIN, URINE, QUALITATIVE |
586 | TSUTSUGAMUSHI (SCRUB TYPHUS) ANTIBODY,SERUM |
587 | TORCH PANEL, IgM |
588 | TORCH PANEL, IgG |
589 | THYROID PROFILE, FREE |
590 | CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE |
591 | CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT HIGH DOSE |
592 | CORTISOL, MORNING & EVENING, SERUM |
593 | TESTOSTERONE STIMULATION BY HCG |
594 | CREATININE CLEARANCE TEST |
595 | C3 & C4 COMPLEMENT PANEL |
596 | CALCIUM, TOTAL & IONIZED |
597 | CYTOMEGALOVIRUS (CMV) ANTIBODIES PANEL, IgG & IgM |
598 | FEBRILE AGGLUTININS PANEL |
599 | FSH & LH |
600 | GLUCOSE, FASTING (F) AND POST MEAL (PP), 2 HOURS |
601 | IMMUNOGLOBULIN PROFILE, SERUM |
602 | RUBELLA (GERMAN MEASLES) ANTIBODIES PANEL, IgG & IgM |
603 | T4, FREE & T3, FREE; FT4 & FT3 |
604 | T4, FREE & TSH ULTRASENSITIVE |
605 | TOXOPLASMA ANTIBODIES PANEL, IgG & IgM |
606 | HERPES SIMPLEX VIRUS (HSV) 1+2 ANTIBODIES PANEL, IgG & IgM, SERUM |
607 | LH & TESTOSTERONE, TOTAL |
608 | PROTEIN, TOTAL, SERUM |
609 | APOLIPOPROTEINS A1 & B |
610 | PSA PROFILE |
611 | TSH STIMULATION BY TRH (THYROTROPIN RELEASING HORMONE) |
612 | THYROID PROFILE, TOTAL |
613 | DIABETES PANEL 1 |
614 | PHOSPHOLIPID ANTIBODIES PANEL, IgG & IgM |
615 | ANTENATAL PANEL BASIC |
616 | DIABETES PANEL BASIC |
617 | DIABETES SCREEN |
618 | ELECTROLYTES, RANDOM URINE |
619 | ELECTROLYTES, 24 HOUR URINE |
620 | FEVER PANEL 1 |
621 | T3 & T4, TOTAL |
622 | BONE MARROW EXAMINATION PANEL 1 |
623 | AMENORRHOEA / ANDROLOGY SCREEN |
624 | BONE MARROW, TREPHINE BIOPSY PANEL |
625 | PERITONEAL EQUILIBRIUM TEST (PET) |
626 | HERPES SIMPLEX VIRUS (HSV) 1 ANTIBODIES PANEL, IgG & IgM, SERUM |
627 | HERPES SIMPLEX VIRUS (HSV) 2 ANTIBODIES PANEL, IgG & IgM, SERUM |
628 | INFERTILITY PANEL, MALES |
629 | PRE-OPERATIVE PANEL |
630 | HISTOPATHOLOGY,SKIN BIOPSY PANEL |
631 | IRON STUDIES MONITORING PANEL |
632 | HYPOTHYROIDISM / HASHIMOTO’S DISEASE PANEL |
633 | HOMA-IR ; INSULIN RESISTANCE INDEX |
634 | HOMA-IR; INSULIN RESISTANCE INDEX, C-PEPTIDE MODEL |
635 | NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) FIBROSIS SCORE |
636 | FATTY LIVER INDEX |
637 | HISTOPATHOLOGY, KIDNEY BIOPSY SECOND OPINION |
638 | ALLERGY,PENICILLIUM NOTATUM |
639 | ALLERGY, MITES |
640 | ALLERGY, GLUTEN (Lasa) |
641 | TROPONIN – T, HIGH SENSITIVE |
642 | ALPHA-1-ANTITRYPSIN QUANTITATION; AAT |
643 | HAPTOGLOBIN |
644 | MYOGLOBIN, SERUM |
645 | TROPONIN – I, HIGH SENSITIVE (hsTnI) |
646 | TUMOUR NECROSIS FACTOR (TNF), ALPHA |
647 | BNP; B – TYPE NATRIURETIC PEPTIDE |
648 | KAPPA / LAMBDA LIGHT CHAINS, FREE, SERUM |
649 | ANTI CYCLIC CITRULLINATED PEPTIDE; ANTI CCP |
650 | GAD-65 (GLUTAMIC ACID DECARBOXYLASE- 65), IgG |
651 | TB GOLD, INTERFERON GAMMA RELEASE ASSAY (IGRA) |
652 | LEPTIN |
653 | P1NP (PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE), TOTAL |
654 | PCOD (POLYCYSTIC OVARIAN DISEASE) PANEL |
655 | ANTI MULLERIAN HORMONE; AMH |
656 | ALDOSTERONE / PLASMA RENIN DIRECT RATIO |
657 | PROCALCITONIN |
658 | NT-PRO BNP (N-TERMINAL PRO B TYPE NATRIURETIC PEPTIDE) |
659 | IMMUNOGLOBULIN IGG SUBCLASS 4 |
660 | ALPHA-2-MACROGLOBULIN |
661 | BILE ACID TOTAL, SERUM |
662 | KETONE BODY (BETA HYDROXYBUTYRATE) SERUM |
663 | CSF LEAKAGE EVALUATION (NASAL/EAR DISCHARGE) |
664 | SOLUBLE TRANSFERRIN RECEPTOR (STFR), SERUM |
665 | ALUMINIUM, DIALYSIS FLUID |
666 | ALUMINIUM, PLASMA |
667 | ALUMINIUM, SERUM |
668 | ARSENIC, 24-HOUR URINE |
669 | ARSENIC, RANDOM URINE |
670 | ARSENIC, BLOOD |
671 | CADMIUM, BLOOD |
672 | CADMIUM, 24-HOUR URINE |
673 | CADMIUM, RANDOM URINE |
674 | CHROMIUM, 24-HOUR URINE |
675 | CHROMIUM, RANDOM URINE |
676 | COBALT, BLOOD |
677 | COBALT, 24-HOUR URINE |
678 | COBALT, RANDOM URINE |
679 | COPPER, 24-HOUR URINE |
680 | COPPER, RANDOM URINE |
681 | LEAD, BLOOD |
682 | LEAD, 24-HOUR URINE |
683 | LEAD, RANDOM URINE |
684 | MERCURY, 24-HOUR URINE |
685 | MERCURY, RANDOM URINE |
686 | SELENIUM, SERUM |
687 | ZINC, 24 HOUR URINE |
688 | ZINC, RANDOM URINE |
689 | ZINC, SERUM / PLASMA |
690 | THALLIUM, BLOOD |
691 | THALLIUM, 24 HOUR URINE |
692 | THALLIUM, RANDOM URINE |
693 | SELENIUM, RANDOM URINE |
694 | SELENIUM, 24-HOUR URINE |
695 | NICKEL, 24-HOUR URINE |
696 | CHROMIUM, BLOOD |
697 | NICKEL, RANDOM URINE |
698 | MANGANESE, 24-HOUR URINE |
699 | MANGANESE, RANDOM URINE |
700 | MANGANESE, BLOOD |
701 | SILVER, SERUM |
702 | METHOTREXATE |
703 | VANCOMYCIN |
704 | PROTEIN ELECTROPHORESIS, 24-HOUR URINE |
705 | OLIGOCLONAL BANDS IgG, CSF |
706 | IMMUNOTYPING, SERUM |
707 | ALKALINE PHOSPHATASE (ALP) ISOENZYMES |
708 | IMMUNOGLOBULIN IgD & IgE TYPING, SERUM |
709 | ACTIVATED PROTEIN C-RESISTANCE; APCR |
710 | OLIGOCLONAL BANDS IgG, CSF & SERUM |
711 | THYROGLOBULIN; Tg |
712 | (CA) CYFRA 21-1; LUNG CANCER MARKER |
713 | NEURON SPECIFIC ENOLASE (NSE), SERUM |
714 | HE4; HUMAN EPIDIDYMIS PROTEIN 4 |
715 | INHIBIN B |
716 | DES-GAMMA CARBOXY PROTHROMBIN (DCP)/PIVKA II, SERUM |
717 | AMINO ACIDS, QUALITATIVE, URINE & PLASMA |
718 | MUCOPOLYSACCHARIDOSIS (MPS) TYPE VI (MAROTEAUX LAMY), QUANTITATIVE, BLOOD |
719 | GALACTOSE, QUANTITATIVE, PLASMA |
720 | GALACTOSEMIA CLASSICAL (TRANSFERASE), QUANTITATIVE, BLOOD |
721 | GALACTOSEMIA PANEL 1 |
722 | GALACTOSEMIA PANEL 2 |
723 | METACHROMATIC LEUCODYSTROPHY, QUANTITATIVE, BLOOD |
724 | NIEMANN PICK DISEASE, QUANTITATIVE, BLOOD |
725 | BIOTINIDASE ACTIVITY, QUANTITATIVE, BLOOD |
726 | IMD PANEL, QUANTITATIVE, BLOOD |
727 | NEWBORN SCREENING, EXTENDED |
728 | PYRUVATE; PYRUVIC ACID |
729 | OROTIC ACID |
730 | CYCLOSPORINE A |
731 | TACROLIMUS; FK506 |
732 | EVEROLIMUS |
733 | SIROLIMUS (RAPAMYCIN) |
734 | SUCCINYLACETONE, BLOOD |
735 | ORGANIC ACIDS, QUANTITATIVE, RANDOM URINE, FULL PANEL |
736 | AMINO ACIDS QUANTITATIVE, BLOOD, 10 AMINO ACIDS |
737 | IMMUNOSUPPRESSANT DRUG PROFILE 2 |
738 | IMMUNOSUPPRESSANT DRUG PROFILE 3 |
739 | CARNITINE, SERUM |
740 | SUCCINYLACETONE, URINE |
741 | CANAVAN DISEASE |
742 | AMINO ACIDS, QUANTITATIVE URINE, 45 AMINO ACIDS / FULL PANEL |
743 | AMINO ACIDS QUANTITATIVE, PLASMA, 45 AMINO ACIDS / FULL PANEL |
744 | AMINO ACID QUANTITATIVE, CSF, 45 AMINO ACIDS / FULL PANEL |
745 | AMINO ACID, NON-KETOTIC HYPERGLYCINEMIA PANEL QUANTITATIVE, CSF & PLASMA |
746 | AMINO ACIDS, MAPLE SYRUP URINE DISEASE (MSUD) PANEL, PLASMA |
747 | UREA CYCLE DISORDER PANEL |
748 | ALKAPTONURIA, URINE, QUANTITATIVE |
749 | VITAMIN D, ULTRASENSITIVE |
750 | ALCOHOL ETHYL GLUCURONIDE (EtG) & ETHYL SULPHATE (EtS), QUANTITATIVE ASSAY, URINE |
751 | HHH SYNDROME; HYPERORNITHINEMIA – HYPERAMMONEMIA – HOMOCITRULLINURIA SYNDROME |
752 | HYDROXYPROLINE, PLASMA |
753 | METHYLMALONIC ACID, QUANTITATIVE, URINE |
754 | METHYLMALONIC ACID, QUANTITATIVE, SERUM |
755 | STEROID PANEL, 21- HYDROXYLASE DEFICIENCY/STRESS DIFERENTIATION |
756 | STEROID PANEL FOR CONGENITAL ADRENAL HYPERPLASIA (CAH) |
757 | “STEROID/ANDROGEN PROFILE FOR POLYCYSTIC OVARY SYNDROME (PCOS) |
758 | “STEROID PANEL FOR PCOS /NON-CLASSICAL CAH DIFFERENTIATION |
759 | STEROID PANEL FOR PREMATURE ADRENARCHE |
760 | STEROID PANEL 1, |
761 | STEROID PANEL 2, 8 STEROIDS |
762 | STEROID PANEL 3, |
763 | CORTISONE, SERUM |
764 | CORTICOSTERONE |
765 | CORTISONE : CORTISOL RATIO |
766 | HYPOGONADISM PANEL, MALES |
767 | METANEPHRINES, FREE, PLASMA |
768 | PROTEIN C, FUNCTIONAL |
769 | ANTITHROMBIN ACTIVITY, FUNCTIONAL |
770 | C1 ESTERASE INHIBITOR, PROTEIN QUANTITATION; C1 INHIBITOR, QUANTITATIVE |
771 | CRYOGLOBULINS PANEL |
772 | LUPUS ANTICOAGULANT BY DRVVT |
773 | FLOW CYTOMETRY, CD 2 |
774 | FLOW CYTOMETRY, CD 3 |
775 | FLOW CYTOMETRY, CD 5 |
776 | FLOW CYTOMETRY, CD 7 |
777 | FLOW CYTOMETRY, CD 10 (CALLA) |
778 | FLOW CYTOMETRY, CD 11c |
779 | FLOW CYTOMETRY, CD 13 |
780 | FLOW CYTOMETRY, CD 14 |
781 | FLOW CYTOMETRY, CD 15 |
782 | FLOW CYTOMETRY, CD 19 |
783 | FLOW CYTOMETRY, CD 20 |
784 | FLOW CYTOMETRY, CD 22 |
785 | FLOW CYTOMETRY, CD 23 |
786 | FLOW CYTOMETRY, CD 25 |
787 | FLOW CYTOMETRY, CD 33 |
788 | FLOW CYTOMETRY, CD 34 |
789 | FLOW CYTOMETRY, CD 38 |
790 | FLOW CYTOMETRY, CD 41a |
791 | FLOW CYTOMETRY, CD 45 |
792 | FLOW CYTOMETRY, CD 61 |
793 | FLOW CYTOMETRY, FMC-7 |
794 | FLOW CYTOMETRY, GLYCOPHORIN |
795 | FLOW CYTOMETRY, HLA DR |
796 | FLOW CYTOMETRY, IgG Heavy Chain (Cytoplasmic) |
797 | FLOW CYTOMETRY, IgG Heavy Chain (Surface) |
798 | FLOW CYTOMETRY, IgM Heavy Chain (Cytoplasmic) |
799 | FLOW CYTOMETRY, IgM Heavy Chain (Surface) |
800 | FLOW CYTOMETRY, Kappa & Lambda Light Chains |
801 | FLOW CYTOMETRY, TdT |
802 | FACTOR II, FUNCTIONAL |
803 | FACTOR V, FUNCTIONAL |
804 | FACTOR IX, FUNCTIONAL |
805 | FACTOR X, FUNCTIONAL |
806 | FACTOR XI, FUNCTIONAL |
807 | FACTOR VII FUNCTIONAL |
808 | FACTOR XII, FUNCTIONAL |
809 | PROTEIN S, FUNCTIONAL |
810 | FLOW CYTOMETRY, CD 103 |
811 | MIXING STUDIES – APTT |
812 | FLOW CYTOMETRY, CD MPO |
813 | FACTOR V LEIDEN MUTATION ANALYSIS |
814 | HIV 1 RNA QUANTITATIVE, REAL TIME PCR WITH CD3 / CD4 (IMMUNE DEFICIENCY PANEL 4) MARKERS |
815 | HIV 1 RNA QUANTITATIVE, REAL TIME PCR WITH CD3, CD4 / CD8 (IMMUNE DEFICIENCY PANEL 2) MARKERS |
816 | FLOW CYTOMETRY, CD 79a |
817 | FLOW CYTOMETRY, CD 117 |
818 | FLOW CYTOMETRY, ZAP-70 |
819 | FLOW CYTOMETRY, CD 138 |
820 | FLOW CYTOMETRY, CD 36 |
821 | FLOW CYTOMETRY, CD 64 |
822 | FLOW CYTOMETRY, CD 123 |
823 | FLOW CYTOMETRY, CD 1A |
824 | FLOW CYTOMETRY, CD 79b |
825 | FLOW CYTOMETRY, CD 34 (STEM CELL) ENUMERATION |
826 | FACTOR VIII FUNCTIONAL |
827 | MENNORHAGIA SCREEN |
828 | DISSEMINATED INTRAVASCULAR COAGULATION (DIC) PROFILE |
829 | PROTEIN S , (FREE) ANTIGEN |
830 | LEUCOCYTE ADHESION DEFICIENCY (LAD I & II) |
831 | CD49D (PROGNOSTIC MARKER FOR B-CLL) |
832 | DOUBLE NEGATIVE T CELLS (DNT) |
833 | IMMUNOHISTOCHEMISTRY, CYTOKERATIN (PANCYTOKERATIN) |
834 | IMMUNOHISTOCHEMISTRY, DESMIN |
835 | IMMUNOHISTOCHEMISTRY, CD 45 (LCA) |
836 | IMMUNOHISTOCHEMISTRY, EPITHELIAL MEMBRANE ANTIGEN (EMA) |
837 | IMMUNOHISTOCHEMISTRY, S100 |
838 | IMMUNOHISTOCHEMISTRY, VIMENTIN |
839 | IMMUNOHISTOCHEMISTRY, NEUROFILAMENT POLYPEPTIDE |
840 | IMMUNOHISTOCHEMISTRY, GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) |
841 | IMMUNOHISTOCHEMISTRY, NEURON SPECIFIC ENOLASE (NSE) |
842 | IMMUNOHISTOCHEMISTRY, CD 45 Ro (PAN T) |
843 | IMMUNOHISTOCHEMISTRY, CATHEPSIN D |
844 | IMMUNOHISTOCHEMISTRY, HER-2 / ERBB2 |
845 | IMMUNOHISTOCHEMISTRY, p53 |
846 | IMMUNOHISTOCHEMISTRY, pS2 |
847 | IMMUNOHISTOCHEMISTRY, Ki67 |
848 | IMMUNOHISTOCHEMISTRY, CD 15 |
849 | IMMUNOHISTOCHEMISTRY, CD 20 |
850 | IMMUNOHISTOCHEMISTRY, CD 30 |
851 | IMMUNOHISTOCHEMISTRY, CD 68 |
852 | IMMUNOHISTOCHEMISTRY, CD 79a |
853 | IMMUNOHISTOCHEMISTRY, CD 3 |
854 | IMMUNOHISTOCHEMISTRY, THYROGLOBULIN |
855 | IMMUNOHISTOCHEMISTRY, ACTIN (Smooth Muscle Actin) |
856 | IMMUNOHISTOCHEMISTRY, EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) |
857 | IMMUNOHISTOCHEMISTRY, PROSTATE SPECIFIC ANTIGEN (PSA) |
858 | IMMUNOHISTOCHEMISTRY, BCL-2 |
859 | IMMUNOHISTOCHEMISTRY, CD 5 |
860 | IMMUNOHISTOCHEMISTRY, CD 10 |
861 | IMMUNOHISTOCHEMISTRY, CD 23 |
862 | IMMUNOHISTOCHEMISTRY, CD 31 |
863 | IMMUNOHISTOCHEMISTRY, CD 34 |
864 | IMMUNOHISTOCHEMISTRY, CD 117 |
865 | IMMUNOHISTOCHEMISTRY, CD 99 (MIC-2) |
866 | IMMUNOHISTOCHEMISTRY, HMB 45 |
867 | IMMUNOHISTOCHEMISTRY, PROLACTIN |
868 | IMMUNOHISTOCHEMISTRY, GROWTH HORMONE |
869 | IMMUNOHISTOCHEMISTRY, FSH |
870 | IMMUNOHISTOCHEMISTRY, ACTH |
871 | IMMUNOHISTOCHEMISTRY, CHROMOGRANIN A |
872 | HISTOPATHOLOGY, BIOPSY, LARGE COMPLEX / CANCER SPECIMEN |
873 | IMMUNOHISTOCHEMISTRY, SYNAPTOPHYSIN |
874 | IMMUNOHISTOCHEMISTRY, CYTOKERATIN 7 |
875 | IMMUNOHISTOCHEMISTRY, CYTOKERATIN 20 |
876 | IMMUNOHISTOCHEMISTRY, TdT |
877 | IMMUNOHISTOCHEMISTRY, CYCLIN-D1 |
878 | IMMUNOHISTOCHEMISTRY, C4d |
879 | IMMUNOHISTOCHEMISTRY, WT-1 |
880 | IMMUNOHISTOCHEMISTRY, AFP (Alpha Feto Protein) |
881 | IMMUNOHISTOCHEMISTRY, LAMBDA LIGHT CHAINS |
882 | IMMUNOHISTOCHEMISTRY, KAPPA LIGHT CHAINS |
883 | IMMUNOHISTOCHEMISTRY, INHIBIN |
884 | IMMUNOHISTOCHEMISTRY, CALRETININ |
885 | IMMUNOHISTOCHEMISTRY, MYELOPEROXIDASE |
886 | IMMUNOHISTOCHEMISTRY, 34-BETA E12 |
887 | IMMUNOHISTOCHEMISTRY, TTF-1 |
888 | IMMUNOHISTOCHEMISTRY, CEA |
889 | IMMUNOHISTOCHEMISTRY, CD 138 |
890 | IMMUNOHISTOCHEMISTRY, POLYOMA BK VIRUS (SV 40) |
891 | IMMUNOHISTOCHEMISTRY, ANY 3 MARKERS |
892 | IMMUNOHISTOCHEMISTRY, ANY 5 MARKERS |
893 | IMMUNOHISTOCHEMISTRY, CD 1a |
894 | IMMUNOHISTOCHEMISTRY, CK 5 / 6 |
895 | IMMUNOHISTOCHEMISTRY, CALCITONIN |
896 | IMMUNOHISTOCHEMISTRY, p63 |
897 | IMMUNOHISTOCHEMISTRY, HEPATOCYTE SPECIFIC ANTIGEN (HSA) |
898 | IMMUNOHISTOCHEMISTRY, CD 56 |
899 | IMMUNOHISTOCHEMISTRY, CD 8 |
900 | IMMUNOHISTOCHEMISTRY, CD 4 |
901 | IMMUNOHISTOCHEMISTRY, SERUM ASSOCIATED AMYLOID (SAA) |
902 | IMMUNOHISTOCHEMISTRY, CYTOMEGALOVIRUS (CMV) |
903 | IMMUNOHISTOCHEMISTRY, IgA |
904 | IMMUNOHISTOCHEMISTRY, IgG |
905 | IMMUNOHISTOCHEMISTRY, DOG-1 |
906 | IMMUNOHISTOCHEMISTRY, CD 21 |
907 | IMMUNOHISTOCHEMISTRY, CD 35 |
908 | IMMUNOHISTOCHEMISTRY, BCL-6 |
909 | IMMUNOHISTOCHEMISTRY, PAX -5 |
910 | IMMUNOHISTOCHEMISTRY, AMACR |
911 | IMMUNOHISTOCHEMISTRY, OCt 2 |
912 | IN-SITU-HYBRIDIZATION- EPSTEIN BARR VIRUS EARLY RNA (EBER-ISH) |
913 | IMMUNOHISTOCHEMISTRY, CALDESMON |
914 | IMMUNOHISTOCHEMISTRY, CDX-2 |
915 | IMMUNOHISTOCHEMISTRY, CYTOKERATIN 19 |
916 | IMMUNOHISTOCHEMISTRY, MELAN-A |
917 | IMMUNOHISTOCHEMISTRY, MYOGENIN |
918 | IMMUNOHISTOCHEMISTRY, HUMAN CHORIONIC GONADOTROPIN (HCG) |
919 | IMMUNOHISTOCHEMISTRY, INI-1 |
920 | IMMUNOHISTOCHEMISTRY, UROPLAKIN – II |
921 | IMMUNOHISTOCHEMISTRY, BETA-CATENIN |
922 | IMMUNOHISTOCHEMISTRT, C-MYC |
923 | IMMUNOHISTOCHEMISTRY, Ber-Ep4 (EpCAM) |
924 | IMMUNOHISTOCHEMISTRY, GATA-3 |
925 | IMUNOHISTOCHEMISTRY, NAPSIN-A |
926 | IMMUNOHISTOCHEMISTRY, GLYPICAN – 3 |
927 | TLE1 (1F5) |
928 | GALECTIN-3 |
929 | PAX 8 |
930 | CD 7 |
931 | TFE 3 |
932 | SALL 4 |
933 | IMMUNOHISTOCHEMISTRY, PD-L1 SP-263 (VENTANA) |
934 | IDH-1 |
935 | IMMUNOHISTOCHEMISTRY ATRX |
936 | IMMUNOHISTOCHEMISTRY, PLA2R (PHOSPHOLIPASE A2 RECEPTOR) |
937 | IMMUNOHISTOCHEMISTRY, CD61 |
938 | IMMUNOHISTOCHEMISTRY, CDK4 |
939 | IMMUNOHISTOCHEMISTRY, E-CADHERIN |
940 | IMMUNOHISTOCHEMISTRY, LH |
941 | IMMUNOHISTOCHEMISTRY, MDM2 |
942 | IMMUNOHISTOCHEMISTRY, MUM1 |
943 | IMMUNOHISTOCHEMISTRY, P16 |
944 | IMMUNOHISTOCHEMISTRY, PLAP |
945 | IMMUNOHISTOCHEMISTRY, SOX10 |
946 | IMMUNOHISTOCHEMISTRY, TSH |
947 | IMMUNOHISTOCHEMISTRY, P40 |
948 | IMMUNOHISTOCHEMISTRY, ALKD5F3 |
949 | HLA T & B CELL LYMPHOCYTE CROSS MATCH |
950 | HLA – PANEL REACTIVE IgG ANTIBODIES (PRA), SCREEN |
951 | HLA-B27, FLOW CYTOMETRY |
952 | HLA – B8 (B*08) |
953 | HLA – B5 (B*51/52) |
954 | HLA – B38 (B*38) |
955 | HLA – B15 (B*15) |
956 | HLA – DR2 (DRB1*02) |
957 | HLA – DR3 (DRB1*03) |
958 | HLA – DR4 (DRB1*04) |
959 | HLA – DR5 (DRB1*11/12) |
960 | HLA – DR7 (DRB1*07) |
961 | HLA – CELIAC DISEASE (DR-DQB1-DQA1 HAPLOTYPE ASSOCIATION INCLUDING DQ2,DQ8) |
962 | HLA – B22 (B*22) |
963 | HLA – Cw6 (C*06) |
964 | HLA – A2 (A*02) |
965 | HLA DSA (DONOR SPECIFIC IgG ANTIBODIES), CLASS I & II |
966 | HLA – B7 (B*07) |
967 | HLA – NARCOLEPSY (DRB1*15, DQB1*06:02, DQA1*01:02) |
968 | HLA B LOCUS TYPING – ANY ANTIGEN |
969 | HLA HYPERSENSITIVITY TO ABACAVIR (B*57;01) |
970 | HLA HYPERSENSITIVITY TO CARBAMAZEPINE & PHENYTOIN (B*15;02) |
971 | HLA HYPERSENSITIVITY TO ALLOPURINOL (B*58;01) |
972 | HLA C LOCUS TYPING, ANY ANTIGEN |
973 | HLA T & B CELL FLOW CYTOMETRY, CROSSMATCH |
974 | HLA – DQB1 TYPING |
975 | HLA CADAVERIC CROSS MATCH |
976 | HLA – DP TYPING |
977 | AFB IDENTIFICATION, RAPID; PNB TEST |
978 | CULTURED AFB ANTITUBERCULAR DST, 4 DRUGS PANEL |
979 | CULTURED AFB ANTITUBERCULAR DST, 5 DRUGS PANEL |
980 | CULTURED AFB ANTITUBERCULAR DST, PYRAZINAMIDE |
981 | CULTURED AFB ANTITUBERCULAR DST, STREPTOMYCIN |
982 | CULTURED AFB ANTITUBERCULAR DST, ISONIAZID |
983 | CULTURED AFB ANTITUBERCULAR DST, RIFAMPICIN |
984 | CULTURED AFB ANTITUBERCULAR DST, ETHAMBUTOL |
985 | CULTURED AFB ANTITUBERCULAR DST, KANAMYCIN |
986 | CULTURED AFB ANTITUBERCULAR DST, AMIKACIN |
987 | CULTURED AFB ANTITUBERCULAR DST, ETHIONAMIDE |
988 | CULTURED AFB ANTITUBERCULAR DST, CAPREOMYCIN |
989 | CULTURED AFB ANTITUBERCULAR DST, CLOFAZIMINE |
990 | CULTURED AFB ANTITUBERCULAR DST, OFLOXACIN |
991 | CULTURED AFB ANTITUBERCULAR DST, PAS |
992 | CULTURED AEROBIC BACTERIA IDENTIFICATION AND SENSITIVITY |
993 | CULTURED AFB ANTITUBERCULAR DST, CYCLOSERINE |
994 | CULTURED AFB ANTITUBERCULAR DST, LEVOFLOXACIN |
995 | CULTURED AFB ANTITUBERCULAR DST, MOXIFLOXACIN |
996 | CULTURED AFB ANTITUBERCULAR DST, RAPID 5 SECOND LINE DRUGS PANEL |
997 | CRYPTOSPORIDIUM ANITGEN, STOOL |
998 | LISTERIA ANTIGEN, STOOL |
999 | ENTEROHEMORRHAGIC E.COLI, VEROTOXIN 1 & 2 ANTIGEN |
1000 | RESPIRATORY SYNCYTIAL VIRUS (RSV), ANTIGEN |
1001 | ENTEROVIRUS ANTIGEN, STOOL |
1002 | ADENOVIRUS ANTIGEN FOR GASTROENTERITIS. STOOL |
1003 | ADENOVIRUS ANTIGEN FOR RESPIRATORY INFECTIONS |
1004 | CAMPYLOBACTER ANTIGEN, STOOL |
1005 | YERSINIA ENTEROCOLITICA ANTIGEN |
1006 | LEGIONELLA ANTIGEN, URINE |
1007 | PNEUMOCYSTIS,IFA |
1008 | CULTURED AFB ANTITUBERCULAR DST, LINEZOLID |
1009 | CULTURED AFB (MYCOBACTERIUM),ANTITUBERCULAR DRUG SENSITIVITY,RAPID SINGLE DRUG * RIFABUTIN* |
1010 | CULTURED AFB (MYCOBACTERIUM),ANTITUBERCULAR DRUG SENSITIVITY,RAPID SINGLE DRUG * CLARITHROMYCIN* |
1011 | TB PLATINUM, INTERFERON GAMMA RELEASE ASSAY (IGRA) |
1012 | PNEUMOSLIDE IGM, IFA |
1013 | CRYPTOCOCCUS ANTIGEN RAPID |
1014 | TYPHOID FEVER PANEL |
1015 | GENEXPERT COMBO.COM*GENEXPERT WITH RIFAMPICIN RESISTANCE* CULTURE AFB, RAPID,AFB STAIN |
1016 | TB LAMP,QUALITATIVE (LOOP MEDIATED ISOTHERMA AMPLIFICATION),DNA, MYCOBACTERIUM TUBERCULOSIS COMPLEX |
1017 | MYCOBACTERIUM TUBERCULOSIS, PCR; MYCOSURE; TB PCR |
1018 | HEPATITIS C VIRAL, PCR, QUALITATIVE; HCV RNA, PCR, QUALITATIVE |
1019 | HEPATITIS B VIRUS, PCR, QUALITATIVE; HBV DNA PCR, QUALITATIVE |
1020 | HERPES SIMPLEX VIRUS (HSV) TYPE I, PCR, QUALITATIVE |
1021 | HERPES SIMPLEX VIRUS (HSV) TYPE 2, PCR, QUALITATIVE |
1022 | CYTOMEGALOVIRUS (CMV), QUALITATIVE PCR |
1023 | VENOUS THROMBOSIS RISK ANALYSIS PANEL |
1024 | HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE, REAL TIME PCR |
1025 | HIV 1 RNA QUANTITATIVE, REAL TIME PCR |
1026 | HEPATITIS C VIRAL RNA, GENOTYPE |
1027 | H1N1 (SWINE FLU) QUALITATIVE, REAL TIME PCR |
1028 | BCR-ABL GENE REARRANGEMENT, PCR QUANTITATIVE |
1029 | BCR-ABL GENE REARRANGEMENT, PCR QUALITATIVE |
1030 | PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUALITATIVE, PCR |
1031 | JAK 2 MUTATION DETECTION, QUALITATIVE PCR |
1032 | HLA – B27, QUALITATIVE PCR |
1033 | AML ETO T(8;21) GENE REARRANGEMENT, PCR QUALITATIVE |
1034 | Inv 16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUALITATIVE, PCR |
1035 | PROTHROMBIN GENE MUTATION ANALYSIS |
1036 | MTHFR (METHYLENE TETRAHYDROFOLATE REDUCTASE) GENE MUTATION, QUALITATIVE PCR |
1037 | INTERLEUKIN 28B rs12979860 & rs 8099917 GENOTYPING, QUALITATIVE, PCR |
1038 | NPM1 GENE MUTATION |
1039 | FLT3 GENE MUTATION |
1040 | CHLAMYDIA TRACHOMATIS, PCR |
1041 | CHIMERISM, POST-ENGRAFTMENT |
1042 | CHIMERISM, PRE-ENGRAFTMENT |
1043 | GENEXPERT ULTRA (NEXT GENERATION) MTB WITH RIFAMPICIN RESISTANCE, SEMI QUANTITATIVE |
1044 | t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1), PCR QUALITATIVE |
1045 | t(12;21) (p13;q22); ETV6-RUNX1 (TEL-AML1), PCR QUALITATIVE |
1046 | t(4;11) (q21;q23); (MLL-AF4), PCR QUALITATIVE |
1047 | t(11;19) (q23;p13.3); (MLL-ENL), PCR QUALITATIVE |
1048 | t(9;11) (p21-22;q23); (MLL-AF9), PCR QUALITATIVE |
1049 | HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE |
1050 | BK VIRUS, PCR, QUALITATIVE |
1051 | TPMT (THIOPURINE METHYL TRANSFERASE) GENOTYPING |
1052 | EGFR, MUTATIONAL ANALYSIS |
1053 | HLA DNA HIGH RESOLUTION TYPING – C LOCUS |
1054 | HLA DNA HIGH RESOLUTION TYPING – DRB1 LOCUS |
1055 | HLA DNA HIGH RESOLUTION TYPING – DQB1 LOCUS |
1056 | HLA DNA HIGH RESOLUTION TYPING – A LOCUS |
1057 | HLA DNA HIGH RESOLUTION TYPING – B LOCUS |
1058 | NEISSERIA GONORRHEA, PCR QUALITATIVE |
1059 | THALASSEMIA BETA, MUTATION ANALYSIS |
1060 | PML RARA T(15;17)(Q22;Q12) GENE REARRANGEMENT QUANTITATIVE, PCR |
1061 | BK VIRUS, PCR, QUANTITATIVE |
1062 | RESPIRATORY PANEL 1 |
1063 | RESPIRATORY PANEL 2 |
1064 | RESPIRATORY PANEL 3 |
1065 | RESPIRATORY PANEL 4 |
1066 | RESPIRATORY PANEL 5 |
1067 | RESPIRATORY PANEL 6 |
1068 | RESPIRATORY PANEL 7 |
1069 | RESPIRATORY PANEL 8 |
1070 | NRAS MUTATION CODON 12, 13 & 61 |
1071 | HEPATITIS E VIRUS DETECTION, PCR |
1072 | TACROLIMUS GENOTYPING (CYP3A5) |
1073 | CALR MUTATION DETECTION |
1074 | BRAF MUTATION ANALYSIS |
1075 | PIK3CA MUTATION ANALYSIS |
1076 | HAINS MYCOBACTERIUM TUBERCULOSIS SECOND LINE DRUG RESISTANCE PROFILE |
1077 | HUNTINGTON DISEASE MUTATION DETECTION |
1078 | SPINAL MUSCULAR ATROPHY (SMA), MUTATION DETECTION |
1079 | SPINAL MUSCULAR ATROPHY (SMA), CARRIER DETECTION |
1080 | MPL (MYELOPROLIFERATIVE LEUKEMIA), GENE MUTATION |
1081 | JAK 2 EXON 12, MUTATION DETECTION |
1082 | HUMAN HERPES VIRUS 7 (HHV7), QUALITATIVE PCR |
1083 | PARVOVIRUS B19, QUALITATIVE PCR |
1084 | ENTEROVIRUSES, QUALITATIVE PCR |
1085 | ADENOVIRUS, QUALITATIVE PCR |
1086 | EPSTEIN BARR VIRUS (EBV), QUALITATIVE PCR |
1087 | VARICELLA ZOSTER VIRUS (VZV), QUALITATIVE PCR |
1088 | HUMAN PARECHOVIRUS. QUALITATIVE PCR |
1089 | HUMAN HERPESVIRUS 6 (HHV6), QUALITATIVE PCR |
1090 | CHIKUNGUNYA VIRUS, PCR QUALITATIVE |
1091 | DENGUE VIRUS, PCR QUALITATIVE |
1092 | SCA-1 (SPINOCEREBELLAR ATAXIA), ATXN1 GENE MUTATION |
1093 | SCA-2 (SPINOCEREBELLAR ATAXIA), ATXN2 GENE MUTATION |
1094 | SCA-3 (SPINOCEREBELLAR ATAXIA), ATXN3 GENE MUTATION |
1095 | SCA-6 (SPINOCEREBELLAR ATAXIA), CACNA1A GENE MUTATION |
1096 | SCA-7 (SPINOCEREBELLAR ATAXIA), ATXN7 GENE MUTATION |
1097 | CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION PANEL 1 |
1098 | CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION PANEL 2 |
1099 | CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION COMPREHENSIVE PANEL |
1100 | SCA-12 (SPINOCEREBELLAR ATAXIA), PPP2R2B GENE MUTATION |
1101 | HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE, ULTRA |
1102 | JAPANESE ENCEPHALITIS VIRUS (JEV), DETECTION PCR |
1103 | BCR-ABL QUANTITATIVE, MRD MONITOR |
1104 | PML RARA T(15;17)(Q22;Q12) GENE REARRANGEMENT QUANTITATIVE, MRD MONITOR |
1105 | AML ETO T(8;21) GENE REARRANGEMENT QUANTITATIVE, MRD MONITOR |
1106 | INV 16 (P13Q22) / T(16;16)(P13;Q22) GENE REARRANGEMENT QUANTITATIVE, MRD MONITOR |
1107 | FLT3 GENE MUTATION QUANTITATIVE, MONITOR |
1108 | NPM1 GENE MUTATION QUANTITATIVE, MRD MONITOR |
1109 | EPSTEIN BARR VIRUS (EBV), PCR QUANTITATIVE |
1110 | MYOTONIC DYSTROPHY TYPE 1 |
1111 | MYOTONIC DYSTROPHY TYPE 2 |
1112 | SCA-8 (SPINOCEREBELLAR ATAXIA), ATXN8OS & ATXN8 GENE MUTATION |
1113 | SCA-17 (SPINOCEREBELLAR ATAXIA), TBP GENE MUTATION |
1114 | DRPLA (DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY) GENE ANALYSIS |
1115 | FRAGILE X TREMOR/ATAXIA SYNDROME; (FXTAS) |
1116 | SICKLE CELL ANEMIA MUTATION DETECTION |
1117 | SCA-14 (SPINOCEREBELLAR ATAXIA), PRKCG GENE MUTATION |
1118 | SCA-23 (SPINOCEREBELLAR ATAXIA), PDYN GENE MUTATION |
1119 | SCA-5 (SPINOCEREBELLAR ATAXIA) SPTBN2 GENE MUTATION |
1120 | SCA-11 (SPINOCEREBELLAR ATAXIA), TTBK2 GENE MUTATION |
1121 | UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE ‘TA’ REPEATS) DETECTION |
1122 | MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) MUTATION DETECTION |
1123 | LEBER’S HEREDITARY OPTIC NEUROPATHY (LHON) MITOCHONDRIAL MUTATION DETECTION |
1124 | LEIGH SYNDROME MITOCHONDRIAL MUTATION DETECTION |
1125 | THALASSEMIA ALPHA, MUTATION ANALYSIS |
1126 | SANGER SEQUENCING, SINGLE VARIANT |
1127 | ANGELMAN SYNDROME |
1128 | BACTERIAL MENINGITIS CONFIRMATORY PANEL |
1129 | BACTERIAL PNEUMONIA PANEL , PCR |
1130 | CEBPA MUTATION DETECTION |
1131 | C-KIT MUTATION DETECTION , PCR |
1132 | CLOSTRIDIUM DIFFICILE DETECTION, PCR |
1133 | CONNEXIN 30 MUTATION DETECTION |
1134 | CYP3A4*22 GENOTYPING |
1135 | FREIDREICHS ATAXIA MUTATION ANALYSIS |
1136 | G6PD GENE MUTATION DETECTION |
1137 | HAPTOGLOBIN GENOTYPING |
1138 | HEPATITIS A VIRUS RNA DETECTION, PCR |
1139 | HEPATITIS D VIRUS DETECTION, PCR |
1140 | HEPATITIS G VIRUS RNA DETECTION , PCR |
1141 | HIV-2 DETECTION , PCR |
1142 | JC/BK VIRUS DETECTION , PCR |
1143 | KRAS CODON 61 MUTATION DETECTION |
1144 | LEPTOSPIRA DETECTION, PCR |
1145 | MALARIA DETECTION , PCR |
1146 | PAN FUNGAL DETECTION , PCR |
1147 | RETT SYNDROME DETECTION |
1148 | RUBELLA DETECTION , PCR |
1149 | TOXOPLASMA DNA DETECTION , PCR |
1150 | TYPHOID DNA DETECTION |
1151 | CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY |
1152 | CHROMOSOME ANALYSIS (KARYOTYPE), BLOOD |
1153 | CHROMOSOME ANALYSIS, PRODUCTS OF CONCEPTION REFLEX TESTING TO FISH FOR ANEUPLOIDY DETECTION |
1154 | CHROMOSOME ANALYSIS, PHILADELPHIA |
1155 | CHROMOSOME ANALYSIS, HIGH RESOLUTION, NEONATAL |
1156 | TESTOSTERONE, FREE |
1157 | ERYTHROPOIETIN; EPO |
1158 | PTH (PARATHYROID HORMONE), INTACT |
1159 | FOLATE (FOLIC ACID), RBC |
1160 | ALDOSTERONE, SERUM |
1161 | ANDROSTENEDIONE |
1162 | CALCITONIN |
1163 | SEX HORMONE BINDING GLOBULIN; SHBG |
1164 | PLASMA RENIN, DIRECT |
1165 | VITAMIN A (RETINOL) |
1166 | CHROMOGRANIN A; CGA |
1167 | DHEA; DEHYDROEPIANDROSTERONE |
1168 | 5-ALPHA-DIHYDROTESTOSTERONE; 5-ALPHA-DHT, SERUM |
1169 | IGF BINDING PROTEIN – 3; IGFBP – 3 |
1170 | IGF – I; SOMATOMEDIN – C |
1171 | OSTEOCALCIN; BONE Gla PROTEIN (BGP) |
1172 | VITAMIN E; TOCOPHEROL |
1173 | VITAMIN D 1, 25-DIHYDROXY |
1174 | VITAMIN D 25 – HYDROXY |
1175 | NGAL (NEUTROPHIL GELATINASE – ASSOCIATED LIPOCALIN), URINE |
1176 | BETA CROSSLAPS; BETA CTx |
1177 | VITAMIN B12, ACTIVE; HOLOTRANSCOBALAMIN |
1178 | CORTISOL, SALIVA |
1179 | VITAMIN B1 (THIAMINE PYROPHOSPHATE), BLOOD |
1180 | LEISHMANIA (KALA AZAR) ANTIBODY IgG |
1181 | MUMPS VIRUS ANTIBODY, IgG |
1182 | ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) |
1183 | SMOOTH MUSCLE ANTIBODY (ASMA), IFA |
1184 | MITOCHONDRIAL ANTIBODY (AMA), IFA |
1185 | ANCA-PR3 (SERIN PROTEINASE 3 ANTIBODIES), EIA |
1186 | ANCA-MPO (ANTI MYELOPEROXIDASE ANTIBODIES), EIA |
1187 | HEPATITIS E ANTIBODY (Anti-HEV), IGM |
1188 | HIV 1 & 2 ANTIBODIES, WESTERN BLOT |
1189 | U1RNP ANTIBODIES |
1190 | EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgG |
1191 | EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgM |
1192 | MEASLES (RUBEOLA) ANTIBODY, IgG |
1193 | MEASLES (RUBEOLA) ANTIBODY, IgM |
1194 | MUMPS VIRUS ANTIBODY, IgM |
1195 | ENDOMYSIAL ANTIBODY, IgA, IFA |
1196 | HELICOBACTER PYLORI, IgG |
1197 | HELICOBACTER PYLORI, IgA |
1198 | SMOOTH MUSCLE ANTIBODY (ASMA), IFA IN DILUTIONS |
1199 | MITOCHONDRIAL ANTIBODY (AMA), IFA IN DILUTIONS |
1200 | PARIETAL CELL ANTIBODY, IFA IN DILUTIONS |
1201 | LYME DISEASE (BORRELIA BURGDORFERI) ANTIBODIES, IgG & IgM |
1202 | ANTI DS DNA ANTIBODY, CRITHIDIA IFA |
1203 | DESMOGLEIN (DSG) 1 AND 3 ANTIBODY |
1204 | STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA), IFA |
1205 | ASPERGILLUS ANTIBODY, IgG, SERUM |
1206 | BACTERIAL MENINGITIS SCREEN |
1207 | ENDOMYSIAL ANTIBODY, IgA, IFA IN DILUTIONS |
1208 | HEPATITIS DELTA ANTIBODY (Anti-HDV), IgM |
1209 | EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUALITATIVE PROFILE |
1210 | ANTI – ds DNA ANTIBODY, CRITHIDIA IFA in DILUTIONS |
1211 | PHOSPHATIDYLSERINE ANTIBODY, IgG |
1212 | PHOSPHATIDYLSERINE ANTIBODY, IgM |
1213 | INSULIN ANTIBODIES |
1214 | ISLET CELL ANTIBODY |
1215 | PARVOVIRUS B19 ANTIBODY, IgG |
1216 | PARVOVIRUS B19 ANTIBODY, IgM |
1217 | ASPERGILLUS ANTIBODY, IgM, SERUM |
1218 | GLIADIN DEAMIDATED ANTIBODY, IgA |
1219 | GLIADIN DEAMIDATED ANTIBODY, IgG |
1220 | LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY, IFA |
1221 | LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN DILUTIONS, IFA |
1222 | ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA |
1223 | ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA IN DILUTIONS |
1224 | STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) , IFA IN DILUTIONS |
1225 | EPIDERMAL (PEMPHIGUS) ANTIBODY, IFA |
1226 | EPIDERMAL (PEMPHIGUS) ANTIBODY, IFA in DILUTIONS |
1227 | HEPATITIS E ANTIBODY (Anti-HEV), IGG |
1228 | ACETYLCHOLINE RECEPTOR (ACHR) BINDING ANTIBODY |
1229 | MYCOPLASMA PNEUMONIAE IGG, SERUM |
1230 | MYCOPLASMA PNEUMONIAE IgM, SERUM |
1231 | TISSUE TRANSGLUTAMINASE TTG-DGP SCREEN |
1232 | TSH RECEPTOR ANTIBODY |
1233 | FECAL CALPROTECTIN |
1234 | GANGLIOSIDE ANTIBODY PROFILE, IgG |
1235 | GANGLIOSIDE ANTIBODY PROFILE, IgM |
1236 | ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) REFLEX TO ENA PROFILE |
1237 | Anti-NMO (NEUROMYELITIS OPTICA ) ANTIBODY /AQUAPORIN 4 |
1238 | ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY |
1239 | PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) |
1240 | GALACTOMANNAN (ASPERGILLUS ANTIGEN), SERUM |
1241 | MuSK (MUSCLE SPECIFIC KINASE) ANTIBODY |
1242 | INTRINSIC FACTOR ANTIBODY |
1243 | MYOSITIS PROFILE |
1244 | ANTI IA-2; INSULINOMA ASSOCIATED ANTIGEN |
1245 | FECAL ELASTASE |
1246 | VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, SERUM |
1247 | SYPHILIS SEROLOGY |
1248 | PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R), QUANTITATIVE |
1249 | SM/RNP ANTIBODY, SERUM |
1250 | PLACENTAL GROWTH FACTOR (PLGF) |
1251 | ANTI NMO (NEUROMYELITIS OPTICA) PANEL, SERUM |
1252 | C. DIFFICILE TOXIN A & B, STOOL |
1253 | PORPHYRINS TOTAL, QUANTITATIVE, 24- HOUR URINE |
1254 | 17 – KETOSTEROIDS, 24–HOUR URINE |
1255 | VMA (VANILMANDELIC ACID), 24 HOUR URINE |
1256 | CATECHOLAMINES FRACTIONATED, 24 HOUR URINE |
1257 | PORPHOBILINOGEN (PBG), QUALITATIVE, URINE |
1258 | VMA (VANILMANDELIC ACID), RANDOM URINE |
1259 | 17 – HYDROXY- CORTICOSTEROIDS (17-OHCS), 24-HOUR URINE |
1260 | 5-AMINOLEVULINIC ACID (5 -ALA), RANDOM, URINE |
1261 | 5-HIAA (5-HYDROXY INDOLE ACETIC ACID), 24-HOUR URINE |
1262 | METANEPHRINES, 24-HOUR URINE |
1263 | HOMOVANILLIC ACID (HVA), 24-HOUR URINE |
1264 | 5 – HIAA (5-HYDROXY INDOLE ACETIC ACID), RANDOM URINE |
1265 | ALDOSTERONE, 24-HOUR URINE |
1266 | CATECHOLAMINES, RANDOM URINE |
1267 | HOMOVANILLIC ACID (HVA), RANDOM URINE |
1268 | METANEPHRINES, RANDOM URINE |
1269 | PORPHYRINS TOTAL, QUALITATIVE, RANDOM URINE |
1270 | OXALATE, 24 HOUR URINE |
1271 | KAPPA / LAMBDA LIGHT CHAINS, FREE, URINE |
1272 | PORPHOBILINOGEN (PBG), QUANTITATIVE, 24 HOUR URINE |
1273 | 5-AMINO LEVULINIC ACID (5-ALA), 24 HOURS URINE |
1274 | OXALATE, RANDOM URINE |
1275 | PHENOL |
1276 | DRUGS OF ABUSE, 7 DRUGS URINE SCREEN |
1277 | FISH: BCR / ABL OR PHILADELPHIA TRANSLOCATION |
1278 | FISH: t(15;17) OR LSI PML/RARA |
1279 | FISH – t(8;21) or LSI ETO/AML1 |
1280 | FISH – inv (16) or LSI CBFB |
1281 | FISH – del 13q or LSI D 13S319 |
1282 | FISH – t(11;14) or LSI IGH/CCNDI |
1283 | FISH – 11q 23 or LSI MLL Gene breakapart |
1284 | FISH – t (12;21) or LSI TEL/AML1 |
1285 | FISH – 14q 32.3 or LSI IGH Gene breakapart |
1286 | FISH – Opposite Sex BMT (XX / XY) |
1287 | FISH – 22q deletion or LSI Di George / VCFS |
1288 | FISH – Prader Willi Syndrome SNRPN |
1289 | FISH – 17 p |
1290 | FISH – SRYGENE |
1291 | FISH – C-MYC |
1292 | FISH – Aneuploidy detection, Products of Conception (POC) using chromosomes 13,18, 21, X and Y |
1293 | FISH – Microdeletion detection for Williams syndrome |
1294 | FISH – t(8;14) or MYC/IGH for Burkitt’s & Non-Hodgkin lymphoma |
1295 | FISH-PDGFR alpha (4q12) GENE REARRANGEMENT |
1296 | FISH-PDGFR beta (5q33) GENE REARRANGEMENT |
1297 | FISH-FGFR1 (8p12) GENE REARRANGEMENT |
1298 | FISH-EWING SARCOMA (EWS), 22q12 (EWSR1) REARRANGEMENT |
1299 | FISH-MET (7q31) AMPLIFICATION |
1300 | CARDIAC / MYOCARDIAL INFARCTION PANEL |
1301 | ANDROSTENEDIONE STIMULATION BY ACTH |
1302 | CORTISOL STIMULATION BY ACTH |
1303 | ANALYZER 26; SMA 26 TEST PANEL |
1304 | PROTEIN & IMMUNOGLOBULIN PANEL |
1305 | HEPATITIS B PROFILE |
1306 | ANALYZER 18; SMA 18 TEST PANEL |
1307 | DHEA STIMULATION BY ACTH |
1308 | 17-HYDROXYPROGESTERONE (17–OHP) STIMULATION BY ACTH |
1309 | LIVER & KIDNEY PANEL |
1310 | TORCH PANEL, IgG & IgM |
1311 | LEAD POISONING PANEL |
1312 | HIRSUTISM PANEL |
1313 | COAGULATION PROFILE 2 |
1314 | COAGULATION PROFILE 1 |
1315 | COMPLETE BODY PANEL |
1316 | THALASSEMIA PROFILE |
1317 | LIPID PROFILE, EXTENDED |
1318 | GROWTH HORMONE SUPPRESSION BY GLUCOSE |
1319 | FSH & LH STIMULATION BY GONADOTROPIN |
1320 | ALBUMIN & IgG, CSF |
1321 | ALLERGY FOOD PANEL 1 |
1322 | AMENORRHOEA PROFILE |
1323 | RHEUMATOID AUTOIMMUNE PANEL |
1324 | ANDROLOGY PANEL |
1325 | EXTRACTABLE NUCLEAR ANTIGENS (ENA), QUANTITATIVE PROFILE |
1326 | CARDIOLIPIN ANTIBODIES PANEL, IgG, IgA & IgM |
1327 | THYROID, COMPREHENSIVE PANEL |
1328 | HELICOBACTER PYLORI ANTIBODIES PANEL, IgA & IgG |
1329 | MACROCYTIC ANEMIA PANEL |
1330 | HEPATITIS B IMMUNITY SCREEN |
1331 | HEPATITIS Be PANEL |
1332 | SJOGREN’S SYNDROME ANTIBODIES |
1333 | RHEUMATOID ARTHRITIS PANEL |
1334 | IMMUNE DEFICIENCY PANEL 1 |
1335 | IMMUNE DEFICIENCY PANEL 2; |
1336 | FLOW CYTOMETRY, – CD 8 |
1337 | IMMUNE DEFICIENCY PANEL 3; CD 3 COUNT |
1338 | HISTOPATHOLOGY, DIRECT IMMUNOFLUORESCENCE (DIF),SKIN / CONJUNCTIVAL BIOPSY, |
1339 | OSTEOPOROSIS PANEL |
1340 | ALLERGY MOLD PANEL |
1341 | ALLERGY DUST PANEL |
1342 | ALLERGY TREE PANEL |
1343 | ALLERGY ANIMAL PANEL |
1344 | HYPERCALCEMIA PANEL 2 |
1345 | NATURAL KILLER CELLS |
1346 | FLOW CYTOMETRY, CD 16 + 56 |
1347 | PHOSPHATIDYLSERINE ANTIBODIES PANEL, IgG & IgM |
1348 | LUPUS ANTICOAGULANT PANEL; LAC PANEL |
1349 | BOH (BAD OBSTETRIC HISTORY) PANEL |
1350 | EPSTEIN BARR VIRUS ANTIBODIES TO VIRAL CAPSID ANTIGEN (VCA), IgG & IgM |
1351 | HYPERCALCEMIA PANEL 1 |
1352 | IGF – I & GROWTH HORMONE PANEL |
1353 | INFERTILITY SCREENING PANEL, FEMALES |
1354 | IMMUNOGLOBULIN IgG SYNTHESIS INDEX & RATE |
1355 | MULTIPLE SCLEROSIS PANEL 1 |
1356 | NEUROBLASTOMA PROFILE, 24-HOUR URINE |
1357 | PARVOVIRUS B19 ANTIBODIES PANEL, IgG & IgM |
1358 | PROTEIN ELECTROPHORESIS & IFE, SERUM |
1359 | MEASLES (RUBEOLA) ANTIBODIES PANEL, IgG & IgM |
1360 | SCLERODERMA PANEL |
1361 | TESTOSTERONE, FREE & SEX HORMONE BINDING GLOBULIN |
1362 | VARICELLA ZOSTER VIRUS (VZV) ANTIBODIES PANEL, IgG & IgM |
1363 | ANTI THYROID ANTIBODIES PANEL |
1364 | GLIADIN DEAMIDATED ANTIBODIES PANEL, IgA & IgG |
1365 | ASPERGILLUS ANTIBODIES PANEL, IgG & IgM, SERUM |
1366 | IMMUNE DEFICIENCY PANEL 4; CD 4 COUNTS |
1367 | FLOW CYTOMETRY, CD 4 |
1368 | IMMUNE DEFICIENCY PANEL 5 |
1369 | KIDNEY STONE FORMATION, DIAGNOSTIC PANEL |
1370 | KIDNEY STONE FORMATION, THERAPEUTIC MONITORING PANEL |
1371 | BREAST CANCER PANEL 1 |
1372 | BREAST CANCER PANEL 2 |
1373 | ARTHRITIS PANEL 1 |
1374 | ARTHRITIS PANEL 2 |
1375 | MATERNAL SERUM SCREEN 3; TRIPLE TEST |
1376 | C-PEPTIDE STIMULATION BY GLUCAGON |
1377 | MYCOBACTERIUM COMBINED PANEL;TB. COM |
1378 | LIPID PROFILE, COMPREHENSIVE |
1379 | DIABETES PANEL 2 |
1380 | ANEMIA PANEL BASIC |
1381 | ANEMIA PANEL 1 |
1382 | OBSTETRIC FLOW PANEL |
1383 | GROWTH HORMONE STIMULATION TEST |
1384 | LEPTOSPIRA ANTIBODIES PANEL, IgG & IgM |
1385 | HERPES SIMPLEX VIRUS (HSV) TYPE 1 & 2, PCR, QUALITATIVE |
1386 | HYPERTENSION PANEL |
1387 | STD PANEL |
1388 | ARTHRITIS PANEL BASIC |
1389 | OBESITY PANEL |
1390 | NEWBORN SCREENING |
1391 | HISTOPATHOLOGY, KIDNEY BIOPSY PANEL 1 |
1392 | HISTOPATHOLOGY, KIDNEY BIOPSY PANEL 2 |
1393 | HEMOPHILIA PANEL |
1394 | PHOSPHOLIPID SYNDROME PANEL |
1395 | KIDNEY DIALYSIS PANEL |
1396 | MUMPS VIRUS ANTIBODIES PANEL, IgG & IgM |
1397 | TESTOSTERONE PANEL, TOTAL & FREE |
1398 | INSULIN, FASTING (F) & POST PRANDIAL (PP), PANEL |
1399 | HISTOPATHOLOGY, LIVER BIOPSY PANEL |
1400 | BREAST METASTATIC MARKER |
1401 | BREAST MONITOR PANEL |
1402 | FEVER PANEL 2 |
1403 | MATERNAL SERUM SCREEN 2; DUAL TEST |
1404 | BONE MARROW EXAMINATION PANEL 2 |
1405 | PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH), CONFIRMATORY TEST |
1406 | ANEMIA PANEL 2 |
1407 | MATERNAL SERUM SCREEN 4; QUADRUPLE TEST |
1408 | PERITONEAL EQUILIBRIUM & ADEQUACY TEST |
1409 | GENEXPERT.COM |
1410 | ALLERGY NON-VEGETARIAN PANEL 1 |
1411 | ALLERGY CEREAL PANEL |
1412 | ALLERGY PULSES PANEL |
1413 | ALLERGY NUT PANEL |
1414 | ALLERGY GRASS PANEL |
1415 | ALLERGY WEED PANEL |
1416 | ALLERGY VEGETABLE COMPREHENSIVE PANEL |
1417 | ALLERGY, ANY 5 ALLERGENS |
1418 | ANTENATAL PANEL 1 |
1419 | BETA 2 GLYCOPROTEIN 1 PANEL, IgG, IgM, IgA |
1420 | ANDROGEN INDEX |
1421 | OVARIAN RESERVE PANEL |
1422 | OSTEOSCREEN PANEL |
1423 | VASCULITIS PANEL |
1424 | HEART SCREEN |
1425 | VITAMIN D SCREEN |
1426 | VITAMIN D COMPREHENSIVE |
1427 | LIVER FIBROSIS PANEL |
1428 | AUTOIMMUNE HEPATITIS PANEL |
1429 | LEUKEMIA GENETIC PROFILE – ANY 6 MARKERS, PCR, QUALITATIVE |
1430 | ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM |
1431 | DENGUE FEVER ANTIBODIES IgG & IgM, EIA |
1432 | ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY), IgA & IgG PANEL |
1433 | BRUCELLA ANTIBODIES, IgG & IgM |
1434 | MYCOPLASMA PNEUMONIAE IgG & IgM, ANTIBODIES PANEL, SERUM |
1435 | ALLERGY ASTHMA / RHINITIS SCREENING PANEL ADULT |
1436 | ALLERGY ASTHMA / RHINITIS SCREENING PANEL PEDIATRIC |
1437 | ALLERGY VEGETABLE PANEL 1 |
1438 | ALLERGY VEGETABLE PANEL 2 |
1439 | ALLERGY VEGETABLE PANEL 3 |
1440 | ALLERGY ECZEMA PANEL FOR VEGETARIANS |
1441 | ALLERGY ECZEMA PANEL FOR NON-VEGETARIANS |
1442 | ALLERGY FOOD PANEL2 |
1443 | ALLERGY FRUIT PANEL 1 |
1444 | ALLERGY, FRUIT PANEL 2 |
1445 | ALLERGY NON-VEGETARIAN PANEL 2 |
1446 | IMMUNOHISTOCHEMISTRY, CUSTOM PANEL |
1447 | CERVICAL SCREEN |
1448 | TORCH PANEL, IgG & IgM EXTENDED |
1449 | TORCH PANEL, IgG EXTENDED |
1450 | TORCH PANEL, IgM EXTENDED |
1451 | CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE, PCR QUALITATIVE |
1452 | LEUKEMIA DIAGNOSTIC PANEL: PLASMA CELL DYSCRASIAS |
1453 | FMF FIRST TRIMESTER SCREEN |
1454 | KIDNEY PANEL EXTENDED |
1455 | HPV, CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA PCR PANEL, QUALITATIVE |
1456 | HYPERTHYROID / GRAVE’S DISEASE PANEL |
1457 | CHRONIC FATIGUE SYNDROME |
1458 | FIBROMYALGIA PANEL |
1459 | OVARIAN CANCER PANEL |
1460 | SEPSIS PANEL |
1461 | MENOPAUSAL SCREENING PANEL |
1462 | INFERTILITY COMPREHENSIVE PANEL, FEMALES |
1463 | GERM CELL TUMOR PANEL |
1464 | SLE (SYSTEMIC LUPUS ERYTHEMATOSUS) PANEL |
1465 | ENHANCED LIVER FIBROSIS (ELF) PANEL |
1466 | METAL SCREEN 1, SERUM |
1467 | PERNICIOUS ANEMIA PANEL |
1468 | HISTOPATHOLOGY, DIRECT IMMUNOFLUORESCENCE (DIF), KIDNEY BIOPSY |
1469 | WILSON DISEASE PANEL |
1470 | HAINS MYCOBACTERIUM TUBERCULOSIS |
1471 | PCOD (POLYCYSTIC OVARIAN DISEASE) COMPREHENSIVE PANEL |
1472 | PRE-ECLAMPSIA PREDICTOR PANEL |
1473 | NEUROVIRUSES PANEL, QUALITATIVE PCR |
1474 | FISH: ROS1 (6q22) REARRANGEMENT |
1475 | FISH: FOLLICULAR LYMPHOMA (IGH/BCL2) t(14;18) |
1476 | CANCER BREAST COMPREHENSIVE PANEL |
1477 | VITAMIN SCREEN |
1478 | IMMIGRATION / IMMUNIZATION CHECK PANEL BASIC |
1479 | ALLERGY: FOOD SCREENING PANEL FOR INDIAN POPULATION |
1480 | ALLERGY: INHALATION SCREENING PANEL FOR INDIAN POPULATION |
1481 | PRE-ECLAMPSIA SCREENING PANEL |
1482 | FIRST TRIMESTER TRIPLE MARKER |
1483 | ALLERGY: PEDIATRIC FOOD & INHALATION SCREENING PANEL FOR INDIAN POPULATION |
1484 | IMMUNOHISTOCHEMISTRY: ROS1 |
1485 | IMMUNOHISTOCHEMISTRY: BRAF V600E |
1486 | MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL |
1487 | LAMOTRIGINE |
1488 | VON WILLEBRAND DISEASE (vWD) PANEL |
1489 | ONCOPRO FOCUS FUSION PANEL FOR SOLID TUMORS |
1490 | TYROSINE KINASE DOMAIN MUTATION ANALYSIS; BCR-ABL1 |
1491 |
|
1492 | IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 3 |
1493 | INTERLEUKIN-6; IL-6 |
1494 | CD35 |
1495 | CD21 |
1496 | VITAMIN B6; PYRIDOXAL 5’-PHOSPHATE (PLP) |
1497 |
|
1498 | FISH: HER2 (ERBB2) AMPLIFICATION |
1499 | BRAF MUTATION ANALYSIS |
1500 | IMMUNOHISTOCHEMISTRY: H3K27m / H3K27me3 |
1501 |
|
1502 | AK 2 V617F REFLEX TO JAK 2 EXON 12 MUTATION DETECTION |
1503 | EGFR EXON 1821 |
1504 | FOOD INTOLERANCE TEST |
1505 | IMMUNOFIXATION ELECTROPHORESIS (IFE), 24-HOUR URINE |
1506 | CPK ISOENZYME ELECTROPHORESIS |
1507 | IMMUNOGLOBULIN IgD & IgE TYPING, URINE |
1508 | IMMUNOSUPPRESSANT DRUG PROFILE 4 |
1509 | IMMUNOSUPPRESSANT DRUG PROFILE 1 |
1510 | AMINO ACIDS, QUANTITATIVE, URINE & PLASMA , 45 AMINO ACIDS / FULL PANEL |
1511 | von WILLEBRAND FACTOR ANTIGEN; vWF Ag |
1512 | HEMOPHILIA A CARRIER DETECTION |
1513 | THROMBOTIC RISK SCREEN |
1514 | T REGULATORY CELLS (TREGS) |
1515 | HLA – AB (CLASS 1) TYPING |
1516 | HLA – DR (CLASS II) TYPING |
1517 | HLA – DR & DQB1 (CLASS II) TYPING |
1518 | HLA – PANEL REACTIVE IgG ANTIBODIES (PRA), CLASS I, QUANTITATIVE |
1519 | HLA – PANEL REACTIVE IgG ANTIBODIES (PRA), CLASS II, QUANTITATIVE |
1520 | HLA – ABC (CLASS 1) TYPING |
1521 | HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I IgG ANTIBODIES |
1522 | HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS II IgG ANTIBODIES |
1523 | HLA DONOR SPECIFIC IgG ANTIBODIES & PANEL REACTIVE ANTIBODIES SCREEN PROFILE |
1524 | CHIMERISM SPLIT CELL ANALYSIS – MYELOID CELL (CD15) |
1525 | HLA DNA TYPING HIGH RESOLUTION BY NEXT GENERATION SEQUENCING (NGS) |
1526 | HLA MIXED ANTIBODY SCREEN – PRA CLASS I, II & MICA |
1527 | HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I & II IGG ANTIBODIES; DSA-SAB CLASS I & II |
1528 | KIR GENOTYPING |
1529 | CULTURED AFB ANTITUBERCULAR DST, 10 DRUGS PANEL |
1530 | CULTURED AFB ANTITUBERCULAR DST, 11 DRUGS PANEL |
1531 | CULTURED AFB ANTITUBERCULAR DST, 12 DRUGS PANEL |
1532 | CULTURED AFB ANTITUBERCULAR DST, 15 DRUGS PANEL |
1533 | CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR SLOW GROWERS |
1534 | CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR RAPID GROWERS |
1535 | CULTURED AFB ANTITUBERCULAR DST, RAPID 10 SECOND LINE DRUGS PANEL |
1536 | CULTURED MOLD ANTIFUNGAL DRUG SENSITIVITY (DST) TEST |
1537 | CULTURED AFB ANTITUBERCULAR DST, 16 DRUGS PANEL |
1538 | CULTURED AFB (MYCOBACTERIUM),ANTITUBERCULAR DRUG SENSITIVITY,RAPID19 DRUGS PANEL |
1539 | HLA DNA TYPING FOR KIDNEY / LIVER TRANSPLANT, PCR |
1540 | HLA DNA TYPING FOR BONE MARROW TRANSPLANT, 10 ANTIGENS, PCR |
1541 | HLA DNA TYPING FOR BONE MARROW TRANSPLANT, 6 ANTIGENS, LUMINEX |
1542 | HEPATITIS B VIRAL DNA (HBV DNA) QUANTITATIVE, REAL TIME PCR |
1543 | CYTOMEGALOVIRUS (CMV), DNA, QUANTITATIVE, PCR |
1544 | HEPATITIS B VIRAL DRUG RESISTANCE & GENOTYPING |
1545 | CHIMERISM, PRE-ENGRAFTMENT, DONOR & RECIPIENT |
1546 | HIV 1 GENOTYPING & DRUG RESISTANCE |
1547 | KRAS MUTATION, CODON 12 & 13 FRAGMENT ANALYSIS |
1548 | IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA |
1549 | MATERNAL BLOOD FOR FETAL DNA |
1550 | GENETIC MAPPING FOR WHOLE GENOME |
1551 | GENETIC MAPPING FOR ONCOLOGY / CANCER |
1552 | CANCER 50 GENE PANEL |
1553 | DNA PROFILING/FINGER PRINTING FOR ESTABLISHING PATERNITY/KINSHIP/LINEAGE STUDIES |
1554 | CHIMERISM SPLIT CELL ANALYSIS – T Cell (CD3) |
1555 | DUCHENNE / BECKER MUSCULAR DYSTROPHY (DMD / BMD) GENE MUTATION |
1556 | NGS NEURO PANEL *ATRX *TP53 * IDH 1 & 2 |
1557 | NGS GASTRO PANEL *ERBB2, *KIT, *BRAF, *PDGFRA, *TP53 |
1558 | NGS LUNG PANEL *MET, *KRAS, *BARF, ERBB2, *EGFR |
1559 | CANCER GENE ANY 3 MARKERS, NGS |
1560 | LIQUID BIOPSY, ctDNA, EGFR |
1561 | HEPATITS E VIRUS (HEV) DETECTION, QUANTITATIVE PCR |
1562 | MICROSATELLITE INSTABILITY (MSI), PCR |
1563 | MATERNAL BLOOD FOR FETAL DNA (NIPT) WITH MICRODELETIONS |
1564 | SPINO-BULBAR-MUSCULAR ATROPHY |
1565 | EPISODIC ATAXIA TYPE 2, CACNA1A GENE MUTATION |
1566 | NOTCH3 MUTATION DETECTION; CADASIL |
1567 | ONCOPRO HEREDITARY CANCER RISK (SCREENS 98 GENES) |
1568 | IGVH MUTATION DETECTION |
1569 | BRCA1 & BRCA2 MUTATION ADVANCED PANEL |
1570 | BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL |
1571 | GLIOMA PROGNOSTIC PANEL |
1572 | MITOCHONDRIAL MUTATION DETECTION COMPREHENSIVE PANEL |
1573 | Nx Gen Whole Exome Sequencing – Illumina |
1574 | Nx Gen Clinical Exome Sequencing – Illumina |
1575 | NX GEN SEQ, ALBINISM |
1576 | NX GEN SEQ, CATARACT |
1577 | NX GEN SEQ, CORNEAL DYSTROPHY |
1578 | NX GEN SEQ, GLAUCOMA |
1579 | NX GEN SEQ, LEBER CONGENITAL AMAUROSIS |
1580 | NX GEN SEQ, MICROPHTHALMIA/ANOPHTHALMIA/COLOBOMA SPECTRUM |
1581 | NX GEN SEQ, OPHTHALMOPLEGIA |
1582 | NX GEN SEQ, OPTIC ATROPHY |
1583 | NX GEN SEQ, RETINITIS PIGMENTOSA |
1584 | NX GEN SEQ, HEREDITARY RETINOBLASTOMA |
1585 | NX GEN SEQ, USHER SYNDROME |
1586 | APO E GENOTYPING |
1587 | COMT GENOTYPING |
1588 | CONNEXIN 26 MUTATION DETECTION |
1589 | CRYTOCOCCUS NEOFORMANS DETECTION, PCR |
1590 | CYP2C19 GENOTYPING |
1591 | CYSTIC FIBROSIS MUTATION DETECTION |
1592 | FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION |
1593 | GALACTOSEMIA (GALT) GENE MUTATION DETECTION |
1594 | MEDULLARY THYROID CARCINOMA, MUTATION DETECTION |
1595 | MERRF (MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED RED FIBRES), MUTATION DETECTION |
1596 | METHYLGUANINE METHYLTRANSFERASE (MGMT) |
1597 | MICM (MATERNALLY INHERITED CARDIOMYOPATHY), MUTATION DETECTION |
1598 | MMC (MATERNAL MYOPATHY WITH CARDIOMYOPATHY), MUTATION DETECTION |
1599 | PAN FUNGAL DETECTION AND IDENTIFICTION, PCR |
1600 | PLASMINOGEN ACTIVATOR INHIBITOR-1/SERPINE-1, 4G/5G GENOTYPING |
1601 | PRADER-WILLI SYNDROME MUTATION DETECTION, METHYLATION SPECIFIC PCR |
1602 | TORCH DNA DETECTION |
1603 | WARFARIN SENSITIVITY DETECTION |
1604 | WT-1 MUTATION DETECTION |
1605 | CAN ASSIST BREAST |
1606 | CHROMOSOME ANALYSIS, SOLID TUMOR |
1607 | CHROMOSOME INTERPHASE PROFILING, PRODUCTS OF CONCEPTION |
1608 | CHROMOFIC CHROMOSOME SNP MICROARRAY 750K, HIGH RESOLUTION |
1609 | CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRODUCTS OF CONCEPTION |
1610 | NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE |
1611 | AUTO IMMUNE ENCEPHATTIS PANEL |
1612 | NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE, ADVANCED |
1613 | NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE, ULTRA |
1614 | FISH – HER2 (ERBB2) amplification |
1615 | FISH – EGFR Gene amplification |
1616 | FISH – 1p and 19q Codeletion |
1617 | FISH – MDS Panel – Chromosomes 5q, 7q, 8q & 20q. |
1618 | FISH – CLL Panel |
1619 | FANCONI’S ANEMIA, STRESS CYTOGENETICS |
1620 | FISH – Multiple Myeloma (5 Probes) |
1621 | FISH – ALK-1 Breakapart Rearrangement |
1622 | FISH-Eosinophilic Leukemia Panel (PDGFRA, PDGFRB, FGFR1 and CBFB) |
1623 | FISH-MYCN AMPLIFICATION |
1624 | FISH – SYNOVIAL SARCOMA (SS18 / SYT ) 18q11.2 GENE REARRANGEMENT |
1625 | C-PEPTIDE RESPONSE TO GLUCOSE, 5 HOURS |
1626 | CALCITONIN STIMULATION BY CALCIUM – PENTAGASTRIN |
1627 | DEEP VEIN THROMBOSIS PANEL; DVT PANEL |
1628 | GASTRIN STIMULATION BY SECRETIN |
1629 | INSULIN RESPONSE TO GLUCOSE, 5 HOURS |
1630 | 17 – HYDROXY- CORTICOSTEROIDS & |
1631 | ALLERGY COMPREHENSIVE PROFILE |
1632 | ALLERGY POST SCREENING PROFILE |
1633 | RHEUMATOID AUTOIMMUNE COMPREHENSIVE PANEL |
1634 | CATECHOLAMINES & VMA, 24-HOUR URINE |
1635 | PHEOCHROMOCYTOMA PROFILE |
1636 | LYMPHOMA DIAGNOSTIC PANEL |
1637 | LEUKEMIA / LYMPHOMA DIAGNOSTIC PANEL: CHRONIC LYMPHOPROLIFERATIVE DISORDERS, T & B CELL |
1638 | LEUKEMIA MONITORING PANEL: HAIRY CELL |
1639 | COLLAGEN DISEASE ANTIBODIES PANEL |
1640 | MYASTHENIA GRAVIS PANEL |
1641 | MULTIPLE SCLEROSIS PANEL 2 |
1642 | GROWTH DISORDER PANEL |
1643 | LEUKEMIA DIAGNOSTIC PANEL: |
1644 | LEUKEMIA DIAGNOSTIC PANEL: |
1645 | LEUKEMIA DIAGNOSTIC PANEL: CLL/HCL/SLL (BASIC) |
1646 | CA 27.29 & CA 15.3 BREAST CANCER MARKERS PANEL |
1647 | THROMBOPHILIA PROFILE |
1648 | THROMBOPHILIA COMPREHENSIVE PROFILE |
1649 | HEPATITIS C VIRAL COMBO |
1650 | LEUKEMIA DIAGNOSTIC PANEL, CUSTOMIZED (ANY 10 MARKERS) |
1651 | ALLERGY FRUIT COMPREHENSIVE PANEL |
1652 | ALLERGY ECZEMA COMPREHENSIVE PANEL |
1653 | ALLERGY WHEEZE / RHINITIS COMPREHENSIVE PANEL PEDIATRIC |
1654 | ALLERGY WHEEZE / RHINITIS COMPREHENSIVE PANEL ADULT |
1655 | AML CATEGORIZATION, PCR |
1656 | LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE 3 |
1657 | ALLERGY, ANY 10 ALLERGENS |
1658 | HEPATITIS B VIRUS GENOTYPING, DRUG |
1659 | LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE, ANY 6 MARKERS |
1660 | IMUNOHISTOCHEMISTRY, MICROSATELLITE INSTABILITY PANEL |
1661 | ACUTE MYELOID LEUKEMIA (AML), CYTOGENETICS PANEL |
1662 | ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), CYTOGENETICS PANEL |
1663 | MULTIPLE MYELOMA SCREENING PANEL |
1664 | ABORTION PANEL |
1665 | FISH – NSCLC (Non-small cell lung cancer) ALK1 & ROS1 |
1666 | LUNG CANCER MUTATION PANEL |
1667 | ACUTE KIDNEY INJURY PANEL |
1668 | RESPIRATORY COMPREHENSIVE PANEL |
1669 | KRAS & NRAS MUTATION ANALYSIS PANEL |
1670 | METAL SCREEN 2, WHOLE BLOOD |
1671 | METAL SCREEN 3, URINE |
1672 | HISTOPATHOLOGY, KIDNEY BIOPSY PANEL 3 |
1673 | MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL |
1674 | JAK 2 V617F REFLEX TO JAK 2 EXON 12, MUTATION DETECTION |
1675 | JAK 2 V617F, CALR & MPL, MUTATION DETECTION PROFILE |
1676 | DIABETES TYPE 1 AUTOIMMUNE PROFILE |
1677 | MULTIPLE MYELOMA MONITORING PANEL |
1678 | SCA (SPINOCEREBELLAR ATAXIA): COMPREHENSIVE PROFILE |
1679 | ACUTE LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE |
1680 | CANCER TARGETED GENE PANEL: COLON / COLORECTAL |
1681 | CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST) |
1682 | CANCER TARGETED GENE PANEL: LUNG |
1683 | CANCER TARGETED GENE PANEL, CNS TUMOR |
1684 | HEPATITIS B MONITORING PANEL |
1685 | HEPATITIS C MONITORING PANEL |
1686 | IMMIGRATION / IMMUNIZATION CHECK PANEL, ADVANCED |
1687 | SCA (SPINOCEREBELLAR ATAXIA) PROFILE: ANY 4 MARKERS |
1688 | NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR |
1689 | MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL |
1690 | VON WILLEBRAND DISEASE (vWD) PANEL |
1691 | ONCOPRO FOCUS FUSION PANEL FOR SOLID TUMORS |
1692 | TYROSINE KINASE DOMAIN MUTATION ANALYSIS; BCR-ABL1 |
1693 | FISH: HER2 (ERBB2) AMPLIFICATION |
1694 | EGFR EXON 1821 |